Stockwinners Market Radar for August 12, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
RMO | Hot Stocks20:02 EDT Romeo Power partners with LG Energy Solution on battery cells through 2028 - Romeo Powe has entered into a long-term supply agreement for lithium-ion battery cells with LG Energy Solution. Under the long-term supply agreement, LG Energy has committed to supplying cells to Romeo Power that equal 8GWh of energy through 2028. Romeo Power expects to use the allocated cells to manufacture battery packs for approximately 29,000 electric vehicles sold or operated by its customers. Romeo Power will facilitate LG Energy's build of an additional assembly line in Ochang, Korea through a recoupable pre-payment of $64.7M. The agreement was approved by both Boards of Directors and became effective on August 10, 2021.
|
PVG | Hot Stocks19:13 EDT Pretium Resources sees FY21 gold production 325K-365K ounces - Cuts FY21 CapEx view to $40M-$45M from $50M-$55M.
|
BYRN | Hot Stocks19:02 EDT Byrna Technologies announces voluntary delisting from CSE - Byrna Technologies Inc. announced that it has filed a request with the Canadian Securities Exchange to voluntarily delist its shares of common stock from the CSE. Byrna's shares will continue to be listed on the NASDAQ Capital Markets. Byrna's shares began trading on the Nasdaq on May 5, 2021 under the symbol "BYRN", with the result that in excess of 95% of the company's shares currently trade on the Nasdaq. Given the volume of trading on the Nasdaq, the company does not expect any adverse impact on the liquidity or value of the company's shares and expects to generate savings in fees and resources associated with a dual listing.
|
CP... | Hot Stocks19:02 EDT Canadian National reaffirms commitment to Kansas City Southern deal - Canadian National (CNI) reaffirmed its commitment to its pro-competitive combination with Kansas City Southern (KSU). "We are pleased that the KCS board of directors has reiterated that the agreed transaction with CN is superior and recommends that stockholders vote FOR our pro-competitive combination," said CN CEO JJ Ruest. "CN and KCS are committed to moving forward to create the premier railway for the 21st century. Together, we will enhance competition, drive economic growth and realize the benefits of a fully end-to-end transportation network connecting North America. We look forward to continuing to work with KCS to deliver this compelling combination to both companies' stakeholders." As previously announced on May 21, 2021, KCS entered into a definitive agreement with CN, pursuant to which CN agreed to acquire KCS in a stock and cash transaction valued at $325 per KCS share. Under the terms of the agreement, which was unanimously approved by the board of directors of each company, KCS stockholders will receive $200 in cash and 1.129 shares of CN common stock for each KCS common share, with KCS stockholders expected to own approximately 12.65% of the combined company. KCS' preferred stockholders will receive $37.50 in cash for each preferred share. The statement comes after Kansas City Southern's board determined that a rival proposal from Canadian Pacific (CP) was not superior to the CN offer.
|
BMBL | Hot Stocks18:23 EDT Bumble CEO: Our platforms are trusted and safe - In an interview on CNBC's Mad Money, Whitney Wolfe Herd said Bumble is seeing "insanely productive growth," partly driven by the pandemic. There is a "serious demand" to find connection and love in times of isolation, she added. According to Herd, customers are coming to Bumble's platforms and finding what they are looking for. The brand is trusted. "Everything from day one has been done with women in mind," she noted. The company is seeing growth in customers looking for platonic relationships, not just love.
|
KSU... | Hot Stocks17:35 EDT Kansas City Southern board determines CP proposal not superior to CN deal - Kansas City Southern (KSU) "announced that its board, following a careful and thorough review in consultation with outside financial and legal advisors, has unanimously determined that the unsolicited proposal received from Canadian Pacific (CP) on August 10, 2021 to acquire KCS in a cash and stock transaction does not constitute a "Company Superior Proposal" and could not reasonably be expected to lead to a "Company Superior Proposal," as defined in KCS' previously announced definitive merger agreement with CN (CNI). The KCS Board reaffirms its recommendation to KCS shareholders to vote in favor of the pro-competitive, end-to-end merger with CN, which will create the premier railway for the 21st century and offers unparalleled opportunities and benefits for customers, employees, shareholders, the environment and the North American economy. CN and KCS' joint voting trust application is currently under review by the Surface Transportation Board."
|
BSX | Hot Stocks17:29 EDT Boston Scientific awarded $265.23M Defense Logistics Agency contract - Boston Scientific has been awarded a maximum $265.23M fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for cardiovascular procedural packages and supplies under the manufacturer direct program. This was a sole-source acquisition using justification 10 U.S. Code 2304, as stated in Federal Acquisition Regulation 6.302-1. This is a five-year contract with no option periods. Location of performance is Massachusetts, with a September 30, 2026, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps and federal civilian agencies. Type of appropriation is FY21 through FY26 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support.
|
NCLH | Hot Stocks17:10 EDT Norwegian Cruise Line says new cruise terminal to be "Shore-Power Ready" by 2023 - Norwegian Cruise Line announced it has partnered with Miami-Dade County to make its new Cruise Terminal B, the Pearl of Miami, and certain homeported vessels "Shore-Power Ready" by fall 2023. The new facility, the Pearl of Miami, can accommodate cruise vessels carrying up to 5,000 cruise passengers. Aapproximately 90% of all subcontractors, vendors and suppliers were local to the region. The new terminal will be fitted to service Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises' shore-power capable vessels.
|
WPM | Hot Stocks17:09 EDT Wheaton Precious Metals raises quarterly dividend to 15c from 14c per share - The dividend will be paid to holders of record of Wheaton Precious Metals common shares as of the close of business on August 27, 2021 and will be distributed on or about September 9, 2021.
|
DIS | Hot Stocks17:07 EDT Disney sees FY21 capital expenditures $3.8B - Says has incredible slate of movies set to release. Says four Marvel feature films to release in 2022. Says theme park reservations remain strong. Says lower results in Q3 from ABC are due to higher programming and production costs. Says ESPN advertising revenue increased by $400M due to return of live sports. Says underlying sports ad marketplace remains strong. Says ESPN+ ended Q3 with 14.9M paid subscribers. Says expects FY21 capex $200M lower than FY20's $4B. Says decided not to declare dividend or repurchase shares in second half. Says values flexibility when it comes to theatrical releases. Says Hulu exceeded expectations. Says Hulu was profitable in Q3. Says Hulu continues to have strong subscriber growth and advertising revenue. Comments and guidance taken from Q3 earnings conference call.
|
MRNA | Hot Stocks17:06 EDT Moderna's new study showing COVID vaccine maintains antibodies for six months - The company says: "Moderna announced the publication of new data on the durability of the Moderna COVID-19 vaccine in generating neutralizing antibodies against variants of concern. The manuscript was published in Science. According to the paper, the majority of individuals vaccinated with the Moderna COVID-19 vaccine maintained both binding and functional antibodies against SARS-CoV-2 variants for six months after the second dose. This study used a variety of assays and showed that after two doses of the Moderna COVID-19 vaccine, binding and neutralizing antibodies were generated against ancestral strain of the virus and against the variants of concern, Alpha, Beta, Gamma, Delta, Epsilon and Iota. While some waning in antibody levels was observed over time, the majority of participants had detectable neutralizing antibody titers at six months after the completion of the primary series. A trend towards lower antibody levels against SARS-CoV-2 spike variants was observed in the oldest individuals at Day 209. Differences were small, however, and there was overlap between age groups. Importantly, many individuals in the oldest group retained neutralizing activity against the variants six months after the second vaccine dose. These data complement other recent observations based on real world evidence demonstrating robust longevity of clinical efficacy of the Moderna COVID-19 vaccine, effectiveness in the face of rising levels of the Delta variant of concern2 and in those harder to treat populations such as those people in long term care facilities, or those patients living with cancer."
|
CORT | Hot Stocks17:02 EDT Corcept Therapeutics appoints William Guyer as Chief Development Officer - Corcept Therapeutics appointed William Guyer as the company's Chief Development Officer, effective August 16. Guyer comes to Corcept from Gilead Sciences, where he most recently served as Senior VP and Global Head of Medical Affairs. Andreas Grauer, previously Corcept's Chief Medical Officer, has become a senior medical advisor to the company.
|
MLM | Hot Stocks17:01 EDT Martin Marietta increases quarterly cash dividend 7% to 61c per share - Martin Marietta announced that its board of directors approved a 7% increase in its quarterly cash dividend, raising it from 57c per share to 61c per share on the company's outstanding common stock. This dividend, which represents a cash dividend of $2.44 per share on an annualized basis, is payable September 30 to shareholders of record at the close of business on September 1.
|
MOS | Hot Stocks16:49 EDT Mosaic reports Potash July sales volumes 629K tons versus 743K tons last year - The Mosaic Company announced its July 2021 sales revenue and volumes for Potash. Potash July sales volumes were 629K tons versus 743K tons in July last year. July sales revenue for Potash was $191M versus $154M in July last year.
|
MBIO | Hot Stocks16:46 EDT Mustang Bio collaborates with Mayo Clinic on Car T technology - Mustang Bio announced that the company has executed an exclusive license agreement with Mayo Clinic for a novel technology that may be able to transform the administration of chimeric antigen receptor engineered T cell therapies and potentially be used as an off-the-shelf therapy. The technology, developed by Larry R. Pease, Ph.D., principal investigator and former director of the Center for Immunology and Immune Therapies at Mayo Clinic, is a new platform to administer CAR T therapy using a two-step approach. First, a peptide is administered to the patient to drive the proliferation of the patient's resident T cells. This is followed by the administration of a viral CAR construct directly into the lymph nodes of the patient. In turn, the viral construct infects the activated T cells and effectively forms CAR T cells in vivo in the patient. Successful implementation may lead to an off-the-shelf product with no need to isolate and expand patient T cells ex vivo. "We are excited by the possibilities that this novel technology has to offer given our ongoing development of CAR T cell therapies in hematologic and solid tumor cancers," said Manuel Litchman, M.D., President and CEO of Mustang. "The potential use of this technology to facilitate how these treatments are delivered to patients can lead to earlier treatment post diagnosis, and using an off-the-shelf therapy may reduce the cost of care, all of which would help bring more innovative treatments to a broader base of patients in need." Mustang plans to file an Investigational New Drug application for a multicenter Phase 1 clinical trial once a lead construct has been identified.
|
ELMS | Hot Stocks16:40 EDT Electric Last Mile Solutions sees FY21 capital expenditures $25M-$30M - Sees FY21 operating expenses $75M-$80M. Says on track for 2022 production volume target laid out in business plan.
|
O VER | Hot Stocks16:40 EDT Realty Income, Vereit shareholders approve merger - Realty Income (O) and Vereit (VER) announced that Realty Income stockholders and Vereit stockholders approved all of the proposals necessary for the closing of the previously announced merger pursuant to which Realty Income will acquire Vereit.
|
MYOV | Hot Stocks16:38 EDT Myovant Sciences appoints Uneek Mehra as Chief Financial and Business Officer - Myovant Sciences announced the appointment of Uneek Mehra as Chief Financial and Business Officer of Myovant Sciences,. Mr. Mehra will succeed Frank Karbe, who has decided to pursue other opportunities and will serve in an advisory capacity to support Mr. Mehra's transition. Beginning September 7, Mr. Mehra will lead Myovant's finance, alliance partnerships, and business development functions and will be a member of Myovant's Executive Committee, reporting to Dave Marek, Myovant's Chief Executive Officer.
|
REPX | Hot Stocks16:38 EDT Riley Exploration sees Q4 CapEx $20M-$26M - Based on current market conditions, the company forecasts fiscal fourth quarter 2021 capital expenditures before acquisitions to total approximately $20M-$26M. Following the successful capital raise in July 2021, the company accelerated the development of its EOR program with estimated fiscal fourth quarter 2021 capital expenditures before acquisitions related to drilling vertical injection wells, purchase of water and gas line infrastructure, and purchase of the CO2 connection equipment. Separately, certain drilling & completions capital expenditures are now forecasted to be invested during the fiscal fourth quarter 2021. Riley Permian forecasts fiscal fourth quarter 2021 oil production to average 6.6 MBbls per day to 7.2 MBbls per day, with total equivalent production to average 8.7 MBoe per day to 9.6 MBoe per day. The Company forecasts full-year fiscal 2021 oil production to average 6.3 MBbls per day to 6.5 MBbls per day, with total equivalent production to average 8.4 MBoe per day to 8.6 MBoe per day.
|
SXI | Hot Stocks16:37 EDT Standex names Flavio Maschera as Chief Innovation & Technology Officer - Standex announced that Flavio Maschera, President of the Engraving segment, is being elevated to Chief Innovation & Technology Officer, a newly created position in the company. Maschera will be succeeded as President of the Engraving segment by James Hooven, currently Vice President of Operations and Supply Chain. Both Maschera and Hooven will continue to report to David Dunbar, CEO and President of Standex.
|
REPX | Hot Stocks16:37 EDT Riley Exploration reports Q3 total net equivalent production 9.1MBoe/d - Reports a net loss of $21.5 million for the three months ended June 30, 2021, with Income from Operations of $19.3 million for the same period.
|
AMR | Hot Stocks16:36 EDT Alpha Metallurgical announces receipt of $70M tax refund - Alpha Metallurgical Resources announced the receipt of its expected $70M tax refund and related interest payment resulting from a net operating loss carryback claim. The company previously disclosed its expectation of receiving the refund before year end.
|
CIVB | Hot Stocks16:32 EDT Civista Bancshares announces $13.5M stock repurchase program - Civista Bancshares announced that the Board of Directors has approved a stock repurchase program authorizing Civista to purchase, from time to time, up to an aggregate $13.5M of its outstanding common shares. This new program replaces the prior share repurchase program approved by the Board of Directors on April 20. Civista had repurchased approximately $12.8M under the previous plan, which had authorized Civista to purchase up to an aggregate of $13.5M of common shares.
|
KAMN | Hot Stocks16:31 EDT Kaman Aerospace selected by Transcend Air to build Vy 400 HSVTOL aircraft - Kaman Corporation announced that its subsidiary, Kaman Aerospace Group, Inc., has been selected by Transcend Air Corporation to build the Vy 400 High Speed Vertical Takeoff and Landing aircraft. The Vy 400 design is optimized to reduce the current time and cost barriers for regional city-to-city travel. The vertical takeoff and landing capabilities of the Vy 400 aircraft gives Transcend Air access to demand-rich centers of major cities. The high-speed Vy 400 travels over 400 miles per hour, making the journey from Manhattan to Boston in 36 minutes. Gregory Bruell, Co-Founder and CEO of Transcend Air said, "Because of the Vy's high speed, we can complete many more passenger trips per aircraft. The combination of that with VTOL is key to our revolutionary economics, and Kaman will be key to us scaling up production to meet the huge demand that our mass market fares will drive."
|
LEA | Hot Stocks16:29 EDT Lear raises quarterly cash dividend to 50c from 25c per share - The dividend is payable on September 21 to shareholders of record at the close of business on September 2.
|
FRGI | Hot Stocks16:29 EDT Fiesta Restaurant reports on Q2 comparable restaurant sales - Comparable restaurant sales at Pollo Tropical increased 43.5%. Compared to the same fiscal period in 2019, comparable restaurant sales for Pollo Tropical decreased 1.8%; Comparable restaurant sales at Taco Cabana increased 15.6%. Compared to the same fiscal period in 2019, comparable restaurant sales for Taco Cabana decreased 6.7%.
|
BALY | Hot Stocks16:28 EDT Bally's acquires Telescope Inc., terms not disclosed - Bally's announced that it has acquired Telescope Inc., a provider of real-time audience engagement solutions for live events, gamified second screen experiences and interactive livestreams. Terms were not disclosed.
|
AWK | Hot Stocks16:25 EDT Indiana American Water acquires River's Edge water, wastewater systems - Indiana American Water President Matt Prine announced the company's acquisition of the River's Edge water and wastewater systems in southeast Indiana. The purchase of the system from Wastewater One, LLC, adds approximately 100 water and 80 wastewater customers to the company's customer base, which represents a population of nearly 300 residents. "The acquisition of this system will help hold rates down for River's Edge customers as needed investments are made and also provide access to operations and capital management water professionals and a number of customer service options and payment methods," said Prine. "Indiana American Water already provides water and wastewater service to several nearby communities, so this is a good fit for us and a continuation of our efforts to expand our presence across Indiana." The acquisition of the River's Edge water and wastewater systems for $420,000 was approved by the Indiana Utility Regulatory Commission in June and closed by Indiana American Water and Wastewater One on Thursday, August 12, 2021. The River's Edge systems will be incorporated into the company's Southern Indiana Operations district, which serves more than 100,000 residents.
|
FUSN | Hot Stocks16:25 EDT Fusion Pharmaceuticals and Triumf expand R&D collaboration for actinium - Fusion Pharmaceuticals and TRIUMF, Canada's particle accelerator centre, have entered into the next phase of their collaboration agreement for the development, production, and supply of actinium-225. Fusion will provide to TRIUMF funding to further develop technology to produce actinium-225 and in return Fusion will have rights, including preferred access and pricing, to the resulting alpha-emitting medical isotope. In December 2020, Fusion and TRIUMF entered a collaboration and supply agreement to develop, produce and procure the supply of actinium-225 to Fusion. As part of this agreement, Fusion will continue its investment of up to C$25M in TRIUMF to advance technology and processes for actinium-225 production.
|
SWIR | Hot Stocks16:23 EDT Sierra Wireless cannot provide FY21 guidance - The company states: "The impact of the COVID-19 pandemic on our global business continues to remain uncertain. While we continue to experience and evaluate the effects on our business, the overall severity and duration of adverse impacts related to COVID-19 on our business, financial condition, cash flows, and operating results for 2021 and beyond cannot be reasonably estimated at this time. Demand for our products remains very strong. However, we are experiencing production interruptions due to COVID-19 cases at a contract manufacturing facility in Vietnam. This is impacting our ability to build and ship cellular embedded modules and gateways to our customers in the third quarter of 2021. While limited production has resumed at the Vietnam facility and we are currently building our resilience by ramping up multiple locations, including our new Mexico site for gateways and routers, the ongoing impact of these interruptions is highly uncertain. This is expected to have a material negative impact on our financial condition and results of operations, including production capacity, revenue, gross margin percentage, gross margin dollars, profit, and cash in the third quarter of 2021. Given these uncertain conditions, we will not be providing guidance for the third quarter of 2021."
|
HEAR | Hot Stocks16:23 EDT Turtle Beach expands partnership with 'League of Legends' streamer KayPea - Turtle Beach announced it has extended and expanded its partnership with League of Legends streamer KayPea. The new multi-year deal encompasses KayPea's continued use of her custom Turtle Beach Elite Pro 2 gaming headsets on stream, and now adds ROCCAT's line of PC accessories, including her favorites - the Kain 200 mouse and Magma keyboard. "KayPea has been an important member of the Turtle Beach family because of her positive spirit and fierce competitiveness," said Ryan Dell, SVP of Global Marketing for Turtle Beach and ROCCAT. "We appreciate all the hard work she does to continue growing her diverse fanbase, and I'm excited to keep working together as we introduce her community to more Turtle Beach gear and to ROCCAT in an even larger and more expansive partnership."
|
SWIR | Hot Stocks16:22 EDT Sierra Wireless reports product revenue up 15.1% - The company states: "Product revenue increased 15.1% year over year to $97.6M, representing 73.5% of consolidated revenue in the quarter. Connectivity, software, and services revenue increased 30.8% year over year to $35.2M, representing 26.5% of consolidated revenue. Monthly recurring revenue was $11.4M in June, a year over year increase of 25.3%."
|
OPGN | Hot Stocks16:22 EDT OpGen continuing to evaluate alternatives for financing future growth
|
OPGN | Hot Stocks16:22 EDT OpGen 'diligently' working on finding new CFO
|
OPGN | Hot Stocks16:22 EDT OpGen awaiting completion of FDA review of AMR Gene Panel for Isolates - The company said: "As we continue into the third quarter, we are waiting for the FDA to complete their review of our AMR Gene Panel for Isolates. We are also in regular dialog with the Chinese NMPA via our strategic partner Beijing Clear Bio. The Chinese NMPA recently requested supplemental clinical data to be generated and submitted in China, and we are working with our partners to finalize study design and swift study execution in due course. We are also working diligently on finding a new CFO to join the OpGen team following the resignation of our current CFO Tim Dec. Together with our board, we are continuing to evaluate alternatives for financing the future growth of OpGen and believe these are steps that will help drive the company forward and on its desired path."
|
LH | Hot Stocks16:20 EDT LabCorp acquires Ovia Health, terms not disclosed - Labcorp announced that it has acquired Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy and parenting. "Patients, doctors and health systems are increasingly using digital health solutions to inform health care and treatment options," said Dr. Brian Caveney, chief medical officer and president, Labcorp Diagnostics. "We're excited to expand our leadership in women's health solutions by bringing Ovia Health's trusted health content and easy-to-use digital platforms to our patients and customers. We welcome Ovia Health's innovative and dedicated team to Labcorp and look forward to bringing the combination of our strengths in women's health to our customers." Specific terms of the transaction were not disclosed.
|
MCW | Hot Stocks16:19 EDT Mister Car Wash targets long-term total topline growth in high-single digits - The company provided the following long-term growth targets: annual unit growth in high single digits; acquired locations of 50 over 5 years; comparable stores sales growth in mid single digits; total topline growth in high single digits; and adjusted EBITDA growth in low double digits.
|
FIXX | Hot Stocks16:18 EDT Homology Medicines sees cash resources funding operations into 1Q23 - As of June 30, 2021, Homology had approximately $213.3 million in cash, cash equivalents and short-term investments. Based on current projections, Homology expects cash resources to fund operations into the first quarter of 2023. Homology is on track to initiate a gene therapy clinical trial for Hunter syndrome, which is designed to evaluate a one-time I.V. administration of HMI-203 in adults, by year end.
|
OSIS | Hot Stocks16:17 EDT OSI Systems receives service orders for $30M for security inspection systems - OSI Systems announced that its Security division received multiple orders for approximately $30M in aggregate for maintenance services of several platforms of cargo, vehicle, and baggage inspection systems. "We are pleased to receive these orders and look forward to continuing service and support for the installed base of inspection systems at these customers," said OSI Systems' Chairman and CEO, Deepak Chopra.
|
RSI | Hot Stocks16:16 EDT Rush Street Interactive names Richard Schwartz CEO - Rush Street Interactive announced that Richard Schwartz, Co-Founder and President, has been promoted to Chief Executive Officer and Greg Carlin has been named Vice Chairman, effective immediately. Mr. Schwartz will also join the Company's Board of Directors. Co-Founder and Executive Chairman of RSI Neil Bluhm commented, "Greg and I have worked alongside Richard since the inception of RSI and I have seen firsthand his immense skill and ingenuity as an executive. Richard's vision has been integral in establishing RSI as a pioneer and nationwide leader in the online casino business, and there is no one better suited to continue to drive our strategic direction and growth. On behalf of the entire Board, I would like to thank Greg for his enduring contributions to the Company and I look forward to his continued partnership."
|
DASH | Hot Stocks16:13 EDT DoorDash: Over 3M people 'dashed' in Q2, more first-time Dashers
|
AEVA | Hot Stocks16:13 EDT Aeva Technologies says on track to deliver on its 2021 objectives - The company said: "Aeva is on track to deliver on its 2021 objectives, which include: Complete next-generation B sample development: Final design in progress and remain on schedule to compete B sample development by year-end; Build on momentum with 2 additional programs towards production: Formed strategic collaboration with Nikon and on track for another program; Accelerate engagements in non-automotive applications: Nikon collaboration accelerates non-auto growth opportunity, including goal to expand beyond industrial metrology; Strengthen supply chain for production to bring Aeva 4D LiDAR to scale: Finalized key supply chain for our silicon processing chip."
|
DASH | Hot Stocks16:13 EDT DoorDash reports Q2 GAAP net loss ($102M) vs. $23M last year
|
IMMR | Hot Stocks16:13 EDT Immersion signs agreement to make haptic technology available to OEMs - The company states: "Immersion announced that the company has signed a license agreement with TITAN Haptics to make Immersion haptic patent licenses available to mobile phone and wearable OEMs that incorporate TITAN's actuators. TITAN Haptics, based in Canada, has developed a groundbreaking new actuator technology called Linear Magnetic Ram that offers new experiences and capabilities in a variety of markets. TITAN Haptics' LMR motors uniquely provide powerful, wideband haptic feedback in a compact form factor with only one internal moving part. LMR motors are ideal for generating diverse haptic feelings in games, music, and other multimedia applications. They can also generate realistic button clicks using impact haptics on the sides of smartphones, allowing OEMs to implement reprogrammable virtual buttons without compromising tactile feel."
|
DASH | Hot Stocks16:12 EDT DoorDash sees FY21 Marketplace GOV $39B-$40.5B, adjusted EBITDA $150M-$350M
|
RKT | Hot Stocks16:12 EDT Rocket Companies sees Q3 closed loan volume $82B-$87B - Sees Q3: Net rate lock volume of between $83B-$90B; Gain on sale margins of 2.70%-3.00%.
|
DASH | Hot Stocks16:12 EDT DoorDash sees Q3 Marketplace GOV $9.3B-$9.8B, adjusted EBITDA $0-$100M
|
DIS | Hot Stocks16:09 EDT Disney up 4% after Q3 earnings, revenue and Disney+ subs beat consensus - Shares are trading at $186.25, up $6.83, or 4% in after-hours.
|
ABNB | Hot Stocks16:09 EDT Airbnb sees Q3 revenue the strongest quarterly revenue on record - The company said: "The stronger than expected recovery in Nights and Experiences Booked through Q2, and the elevated ADR year-to-date have created a strong GBV backlog for peak travel season revenue. As a result, we expect Q3 2021 to be our strongest quarterly revenue on record, finishing well above Q3 2019 levels. Our Q3 revenue as a percentage of GBV will increase substantially from Q2 due to the high concentration of check-ins expected in Q3. We expect our Adjusted EBITDA margins to be higher in the second half of 2021 than in the first half, both due to seasonality and timing of certain investments made in the first half of 2021."
|
SMSI | Hot Stocks16:08 EDT Smith Micro names Michael Fox as interim CFO - The company states: "Smith Micro announced that as part of the orderly transition to replace Tim Huffmyer as CFO, the company has hired Mike Fox as its interim Vice President of Finance. Following Mr. Huffmyer's departure, Mr. Fox will serve as the company's interim CFO while the company continues its search for a permanent CFO over the next several months."
|
ABNB | Hot Stocks16:08 EDT Airbnb sees Nights and Experiences booked in Q3 significantly outperforming y/y - The company said: "while we expect Nights and Experiences Booked in Q3 2021 to significantly outperform Q3 2020, we expect Nights and Experiences Booked to come down from Q2 and remain below Q3 2019 levels. In the second half of 2021, we expect ADR to gradually moderate based on the anticipated shift in regional composition and return to urban destinations. Despite this moderation in ADR, we expect GBV in Q3 2021 to be well above 2019 levels, but below what we saw in Q2 due to the impact of booking timing differences and cancellations."
|
DIS | Hot Stocks16:08 EDT Disney sees COVID-19 related costs of $1B in FY21 - Disney said: "Since early 2020 and continuing into 2021, COVID-19 and measures to prevent its spread have impacted our segments in a number of ways, most significantly at the Disney Parks, Experiences and Products segment where our theme parks and resorts have been closed and cruise ship sailings and guided tours have been suspended. Theme parks and resorts resumed operations, generally at reduced capacity, at various points since May 2020 through June 2021 and we have commenced an ongoing return of cruise ship sailings and guided tours. In addition, we have delayed, or in some cases, shortened or canceled, theatrical releases, and stage play performances were suspended beginning in March 2020 with limited stage play operations resuming in the first quarter of fiscal 2021. Theaters have been subject to capacity limitations and shifting government mandates or guidance regarding COVID-19 restrictions. We have experienced disruptions in the production and availability of content, including the delay of key live sports programming during fiscal 2020 and fiscal 2021, as well as the suspension of most film and television production in March 2020. Although most film and television production resumed beginning in the fourth quarter of fiscal 2020, we continue to see disruption of film and television production, as well as live sports events, depending on local circumstances. Fewer theatrical releases and production delays have limited the availability of film content to be sold in the subsequent home entertainment and TV/ SVOD distribution windows. We have and will continue to incur additional costs to address government regulations and implement safety measures for our employees, talent and guests. The timing, duration and extent of these costs will depend on the timing and scope of our operations as they resume as well as regulatory or other requirements. We currently expect these costs will total approximately $1 billion in fiscal 2021. Some of these costs may be capitalized and amortized over future periods."
|
ABNB | Hot Stocks16:07 EDT Airbnb: Travel rebound 'upon us' - In its Q2 shareholder letter, Airbnb said: "As vaccinations rise and restrictions ease, more people are traveling. We saw strong demand for bookings in Q2, achieving the highest gross nights booked of any quarter in our history. Guests from countries with high vaccination rates, including the U.S. and parts of Europe, are driving the travel recovery. Even as pre-pandemic types of travel rebound, we believe many new booking trends are here to stay, including stays outside of top destinations and long-term stays."
|
DIS | Hot Stocks16:06 EDT Disney reports 116.0M Disney+ paid subscribers as of July 3 - Reports Disney+ paid subscribers of 116.0M, up from 57.5M last year. Reports ESPN+ paid subscribers 14.9M vs. 8.5M last year. Reports total Hulu paid subscribers 42.8M vs. 35.5M last year.
|
ABNB | Hot Stocks16:06 EDT Airbnb reports Q2 gross booking value $13.4B
|
AGNC | Hot Stocks16:04 EDT AGNC Investment reports estimated tangible net book value of $16.28 per share - The company announced its estimated tangible net book value of $16.28 per common share as of July 31. The estimate of tangible net book value includes a deduction for the company's July dividend of 12c per common share, which was declared on July 8 with a July 30 record date.
|
CVV | Hot Stocks16:01 EDT CVD Equipment gets first production systems order for nanomaterials - CVD Equipment announced that it has received a production system order from a major, US-based, electric vehicle battery material manufacturer for approximately $1.7M. The system is planned to ship to the customer in the first quarter of 2022.
|
BLBD | Hot Stocks15:49 EDT Micro Bird acquires controlling interest in Ecotuned - Micro Bird Holdings, a Blue Bird and Girardin joint venture, has acquired a controlling interest in the EV drivetrain integrator and supplier GranTuned Automobiles (Ecotuned). This strategic acquisition firmly positions Micro Bird for substantial growth in the light and medium duty EV market by bringing core electrification-expertise and value to both Micro Bird and the broader Blue Bird Corporation. "Over the years, Micro Bird has evaluated many up-and-coming EV companies and found in Ecotuned a more optimized, efficient and technologically-advanced solution that is faster to install, due to its patented cradle system, and does not compromise on safety and performance," said Steve Girardin, president of Micro Bird.
|
BPOP | Hot Stocks15:23 EDT Popular EVP Chinea sells 8,000 common shares - In a regulatory filing, Popular executive VP Manuel Chinea disclosed the sale of 8,000 common shares of the company on August 11 at a price of $75.70 per share.
|
FRLN | Hot Stocks14:56 EDT Freeline treatment of Gaucher Disease granted orphan designation - Freeline Therapeutics' treatment of Gaucher Disease was granted FDA orphan designation, according to a post to the agency's website. Reference Link
|
UP | Hot Stocks14:35 EDT Wheels Up revenue more than doubles as loss widens - Wheels Up (UP) is in the spotlight on Thursday after the private-flying service company reported a widened net loss for the quarter as revenue more than doubled amid higher membership totals. This was the company's first earnings report as a public company after going public via a SPAC-merger last month. RESULTS: For the second quarter, Wheels Up reported a net loss of ($29M), compared with a loss of ($27.4M) a year ago. The company also reported revenue of $285.6M for the quarter, compared to $134.3M a year earlier. Additionally, Wheels Up said its tally of active users rose 27% year-over-year to over 11,000. PRICE ACTION: In Thursday afternoon trading, shares of Wheels Up have gained about 2% to $8.88.
|
CZR | Hot Stocks14:34 EDT Caesars, Houston Texans announce multi-year partnership - Caesars Entertainment announced an agreement with the Houston Texans to become the official casino partner of the team. The partnership goes into effect immediately before the 2021 NFL season kicks off. As part of the agreement, Caesars Rewards will sponsor the free-to-play "Schedule Pick 'Em" game, available on the Texans official mobile app. Leading up to the NFL schedule release, fans can submit their matchup predictions for a chance to win exclusive prizes such as a paid trip to a Caesars Entertainment destination property, game tickets, and more. Additionally, at each game, one Texans season ticket holder will be selected for a chance to win an all-inclusive trip to Las Vegas. As part of the partnership, Caesars Rewards will be integrated into the team's promotional channels, including in-stadium signage and digital and traditional media assets.
|
JAZZ | Hot Stocks14:33 EDT Jazz announces U.S. FDA approval of Xywav for idiopathic hypersomnia - Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration approved Xywav oral solution for the treatment of idiopathic hypersomnia in adults. The company plans to make Xywav available to patients with idiopathic hypersomnia later this year following Risk Evaluation and Mitigation Strategies, or REMS, implementation, it stated. "We are excited that with today's approval Xywav will become the first and only medicine indicated to treat idiopathic hypersomnia, a unique medical condition that can have significant effects on the lives of those diagnosed with the condition," said Bruce Cozadd, chairman and CEO of Jazz Pharmaceuticals.
|
AJRD LMT | Hot Stocks14:31 EDT Aerojet Rocketdyne dips after Bloomberg report on Khan's reply to Warren - Shares of Aerojet Rocketdyne (AJRD) are down 3% to $45.03 in afternoon trading after Bloomberg reported on a letter sent by FTC Chair Lina Khan to Senator Elizabeth Warren, who had written to the agency about deals in the defense industry, such as Lockheed Martin's (LMT) deal to buy Aerojet Rocketdyne. In the letter, Khan said antitrust officials should more frequently move to block mergers that threaten competition rather than finding remedies and approving such deals, according to Bloomberg's account of the communication.
|
PCOM | Hot Stocks14:18 EDT Points International rises following 'strong' quarterly results - Shares of Points International (PCOM) are on the rise after the company reported better than expected quarterly results. Following the earnings release, Northland analyst Greg Gibas upgraded the stock to Outperform as he believes increasing vaccinations accompanied by a broader recovery in the travel and hospitality industries, strong consumer confidence, and pent-up travel demand set Points up for growth in the second half of 2021 and 2022. RESULTS: Points International reported second quarter earnings per share of 3c, which was better than the expected loss per share of (6c), according to Zacks Consensus Estimate. This also compares to a loss of (11c) per share a year ago. Additionally, the company reported revenue of $103M for the quarter. This compares to year-ago revenue of $40.9M. BUY POINTS: Northland analyst Greg Gibas upgraded Points International to Outperform from Market Perform with a price target of $22, up from $17.50, after the company reported "strong" second quarter results that were ahead of consensus estimates and realized an acceleration of promotional activity as well as improving transaction activity tied to near-term travel. Despite concerns of the Delta variant, the analyst likes that increasing vaccinations accompanied by a broader recovery in the travel and hospitality industries, strong consumer confidence, and pent-up travel demand set Points up for growth in the second half of 2021 and 2022. PRICE ACTION: In Thursday afternoon trading, shares of Points International have gained over 5% to $16.64.
|
DISCA DISCK | Hot Stocks14:11 EDT Discovery to charge government of Poland with violations of treaty - Discovery, Inc. today announced that it has formally notified the Polish government that it will take legal action under the bilateral investment treaty between the United States of America and the Republic of Poland. JB Perrette, President and CEO of Discovery International, said: "Discovery has successfully operated and invested in Poland for nearly 25 years, making us now one of the biggest international investors and employers in this incredible country. The current Polish government's damaging and discriminatory actions, however, leave us no choice but to bring charges under the US-Poland bilateral investment treaty. We are deeply committed to safeguarding our investment in Poland and its people, defending the public's interest in independent media and the rights of freedom of expression. Discovery, as a protected investor in Poland, is afforded important rights and freedoms under the US-Polish Treaty. We do believe this legislation will have a chilling effect on U.S. and European investment into the Polish economy, and we will aggressively defend our rights." The company added: "Poland's conduct violates several obligations under the Treaty signed between the US and the Republic of Poland on 21 March 1990. The obligations include fair and equitable treatment, non-impairment by arbitrary and discriminatory measures, non-discrimination in granting licenses, and the prohibition on expropriation without compensation."
|
RSI | Hot Stocks14:09 EDT Rush Street Interactive enters into sports betting partnerhsip with CLC - Rush Street Interactive, Inc. announced that it has been selected by the Connecticut Lottery Corporation as its sports betting operations partner for the CLC's soon-to-launch sports wagering business. Through this 10-year agreement and subject to regulatory approvals, RSI will serve as the CLC's exclusive provider of a state-of-the-art sports betting system for mobile, online, and retail channels, as well as the operator of the CLC's mobile/online sportsbook. "We are honored to be selected by the CLC to bring sports betting to the state and people of Connecticut," said Richard Schwartz, President of RSI. "This partnership represents a significant milestone for RSI, as the trust and confidence of a state-backed organization such as the CLC further validates the strength of our award-winning online gaming platform and customer service. Building on our proven track record of success in the tri-state area, where RSI was an early entrant in New Jersey and is the market leader in retail sports betting amongst New York's commercial casinos, we are thrilled to collaborate with the CLC team to offer Connecticuters safe, convenient, and unique gaming experiences."
|
CTAS | Hot Stocks14:05 EDT Cintas appoints Nageleisen VP of Environment, ESG and Chief Compliance Officer - Cintas Corporation has promoted Deputy General Counsel-Litigation Christy Nageleisen to the newly created position of Vice President of Environment, Social and Governance, ESG, and Chief Compliance Officer. In the new role, Nageleisen will oversee the company's integrated ESG efforts, including the development of a new enterprise-wide strategy and ESG-monitoring, reporting and compliance. Nageleisen will also lead and manage the company's product and service compliance efforts, risk insurance programs, and other corporate, federal, state and local compliance efforts. She will continue to report to Cintas General Counsel D. Brock Denton.
|
BGPPF | Hot Stocks13:23 EDT BGP Acquisition confirms discussions regarding qualifying transaction - The company said, "BGP Acquisition is aware of an article dated today regarding a potential qualifying transaction for the Corporation. The Corporation confirmed that it is in discussions regarding a qualifying transaction, but has not finalized definitive agreements in respect of a qualifying transaction and will disclose details regarding any potential transaction if and when it is legally required or otherwise appropriate to do so."
|
TRMB... | Hot Stocks13:18 EDT Trimble forms partnership with Google over Android Enterprise - Frej Krook, collaboration community manager for employee tools at Trimble (TRMB), said in a blog post that Google's (GOOGL) Android Enterprise is a "key" for the company to keep everyone connected securely. "Keeping a global business like Trimble connected is no small amount of work. Our hybrid teams create solutions for a wide range of industries - helping farmers achieve better outcomes through data analysis, offering hardware for geospatial mapping and improving transportation efficiency," Krook said. "Android Enterprise is one of our keys to keeping everyone connected securely, combining strong security controls with the flexibility to get anyone the apps they need. It simplifies how we manage and protect the thousands of Android devices on our network. The vast majority of these devices are employees' personal phones enrolled with the work profile; our data and apps are securely managed, while our teams have privacy over their personal data and flexibility to disconnect." "We see Android Enterprise as the ideal device management solution for Trimble," Krook added. "Employees get a better user experience, and we spend less time on support. We believe Android Enterprise will continue to play a central role in our device strategy to give our teams the flexibility they want in how they work and to achieve better balance with their personal time."
|
TKC | Hot Stocks12:11 EDT Turkcell trading resumes
|
PM... | Hot Stocks12:10 EDT Vectura directors to recommend Philip Morris offer to shareholders - In a statement to the London Stock Exchange, Vectura Directors noted: "The announcement made on 8 August 2021 by PMI Global Services Inc., a wholly owned direct subsidiary of Philip Morris International Inc., of a revised cash offer of 165 pence per Vectura Share to be implemented by way of takeover offer, and that as PMI did not make an announcement prior to 5.00pm on 12 August 2021, in accordance with the statement of the Takeover Panel made on 9 August 2021 the revised cash offer of 165 pence per Vectura Share is PMI's final offer for Vectura; and the announcement made on 6 August 2021 by Murano Bidco Limited, a newly formed company indirectly controlled by funds managed by Carlyle Europe Partners V, of a revised cash offer of 155 pence per Vectura Share to be implemented by a scheme of arrangement, which it announced on 10 August 2021 was its final offer for Vectura. The price of 165 pence per Vectura Share payable under the terms of the Final PMI Offer is superior to the price of 155 pence per Vectura Share payable under the terms of the Final Carlyle Offer and represents: a premium of 10 pence (approximately 6.5 per cent) to the Final Carlyle Offer; an increase of 29 pence (approximately 21.3 per cent) to the offer announced by Carlyle on 26 May 2021, being the first offer received by Vectura; a premium of approximately 60.2 per cent to the Ex-Dividend Closing Price per Vectura Share of 103 pence on 25 May 2021 (being the last Business Day prior to commencement of the offer period in relation to Vectura); a premium of approximately 70.6 per cent to the volume weighted average Ex-Dividend Closing Price of 97 pence per Vectura Share for the 3 months ended 25 May 2021 (being the last Business Day prior to commencement of the offer period in relation to Vectura); and an aggregate value of approximately GBP 1.1 billion for the entire issued and to be issued ordinary share capital of Vectura. The Vectura Directors, who have been so advised by J.P. Morgan Cazenove and Rothschild & Co as to the financial terms of the Final PMI Offer, consider the terms of the Final PMI Offer to be fair and reasonable. In providing their financial advice to the Vectura Directors, J.P. Morgan Cazenove and Rothschild & Co have taken into account the commercial assessments of the Vectura Directors. Rothschild & Co is providing independent financial advice to the Vectura Directors for the purposes of Rule 3 of the Takeover Code. The Vectura Directors appreciate Carlyle's interest in Vectura over this lengthy process and their support for Vectura's strategy to become one of the market leading CDMOs in the inhalation segment. However, the Vectura Directors recognise the superior cash price the Final PMI Offer provides Vectura shareholders. The Vectura Directors also note that wider stakeholders could benefit from PMI's significant financial resources and its intentions to increase research and development investment and to operate Vectura as an autonomous business unit that will form the backbone of its inhaled therapeutics business. Accordingly, following careful consideration of these factors and their fiduciary duties, the Vectura Directors intend to unanimously recommend the PMI Offer to Vectura shareholders. As a result, the Vectura Directors do not intend to reconvene the shareholder meetings required in relation to the approval and implementation of the Carlyle Scheme. Due to PMI switching from a scheme of arrangement to a takeover offer, as announced on 10 August 2021, the Vectura Directors intend to adjourn the shareholder meetings required in relation to the approval and implementation of this scheme of arrangement."
|
JOBY | Hot Stocks12:06 EDT Joby Aviation falls -14.3% - Joby Aviation is down -14.3%, or -$1.92 to $11.48.
|
SLQT | Hot Stocks12:06 EDT SelectQuote falls -16.1% - SelectQuote is down -16.1%, or -$2.78 to $14.50.
|
FOA | Hot Stocks12:06 EDT Finance of America falls -19.8% - Finance of America is down -19.8%, or -$1.33 to $5.39.
|
PLTR | Hot Stocks12:06 EDT Palantir rises 12.1% - Palantir is up 12.1%, or $2.70 to $25.05.
|
BHG | Hot Stocks12:06 EDT Bright Health rises 12.3% - Bright Health is up 12.3%, or $1.03 to $9.47.
|
DOCS | Hot Stocks12:00 EDT Doximity rises 13.3% - Doximity is up 13.3%, or $9.37 to $79.78.
|
TKC | Hot Stocks11:37 EDT Turkcell trading halted, news pending
|
UNH | Hot Stocks11:23 EDT UnitedHealth to pay $14.3M in restitution in settlement with NY AG, U.S. DOL - New York Attorney General Letitia James and the U.S. Department of Labor announced agreements with UnitedHealthcare to resolve allegations that United unlawfully denied health care coverage for mental health and substance use disorder treatment for thousands of Americans. As a result of these agreements, United will pay approximately $14.3M in restitution to consumers affected by the policies, including $9M to more than 20,000 New Yorkers with behavioral health conditions who received denials or reductions in reimbursement. New York and federal law requires health insurance plans to cover mental health and substance use disorder treatment the same way they cover physical health treatment, the AG said in a statement. The agreements - which resolve investigations and litigation - address United's policies that illegally limited coverage of outpatient psychotherapy, hindering access to these vital services for hundreds of thousands of New Yorkers for whom United administers behavioral health benefits. In addition to the payment to impacted consumers, United will lift the barriers it imposed and pay more than $2M in penalties, with $1.3M going to New York state. "In the shadow of the most devastating year for overdose deaths and in the face of growing mental health concerns due to the pandemic, access to this care is more critical than ever before," said Attorney General James. "United's denial of these vital services was both unlawful and dangerous - putting millions in harm's way during the darkest of times. There must be no barrier for New Yorkers seeking health care of any kind, which is why I will always fight to protect and expand it." Reference Link
|
ADDYY AUTH | Hot Stocks11:19 EDT Adidas to sell Reebok to Authentic Brands Group for up to EUR 2.1B - adidas (ADDYY) announced that it has entered into a definitive agreement to sell Reebok to Authentic Brands Group (AUTH) for a total consideration of up to EUR 2.1B, with the majority to be paid in cash at closing of the transaction and the remainder comprised of deferred and contingent consideration. The closing of the transaction is subject to customary closing conditions and is expected to occur in the first quarter of 2022. "adidas intends to share the majority of the cash proceeds to be received upon closing with its shareholders," the company stated. The sale of Reebok has no impact on adidas' financial outlook for the current year or the company's 2025 financial ambition that was announced as part of its Own the Game strategy in March of 2021, the company added. Jamie Salter, Founder, Chairman and CEO of ABG commented, "It's an honor to be entrusted with carrying Reebok's legacy forward. This is an important milestone for ABG, and we are committed to preserving Reebok's integrity, innovation, and values - including its presence in bricks and mortar. We look forward to working closely with the Reebok team to build on the brand's success." Authentic Brands Group has filed with the SEC for an initial public offering, previously stating that it intends to have its Class A common stock listed on the New York Stock Exchange under the symbol "AUTH." Reference Link
|
USB | Hot Stocks11:02 EDT U.S. Bank to acquire Bento Technologies, terms not disclosed - U.S. Bank has entered into an agreement to acquire Bento Technologies, a fintech company based in Chicago and San Francisco that provides payment and expense management services to small and mid-size businesses. The company said, "The innovative Bento platform offers businesses simple and easy-to-use tools to better manage card-based payments and other expenses via spend tracking and card transaction controls. The acquisition is part of the vision at U.S. Bank to bring payments and banking services together to simplify cash flow and money management for small businesses. Bento's accounts payable-based software complements the bank's existing Elavon and talech accounts receivable software solutions, providing U.S. Bank clients a holistic one-stop experience for both their accounts payable and accounts receivable needs." The purchase agreement was signed on Aug. 11, 2021 and the transaction is expected to close in September. Financial details of the transaction were not disclosed.
|
LORL | Hot Stocks10:08 EDT Telesat to receive $1.44B through Government of Canada incestment - Telesat announced that it expects to receive a $1.44 billion investment from the Government of Canada to support Telesat Lightspeed, the world's most advanced Low Earth Orbit satellite network. This investment will drive economic growth and innovation in Canada and help ensure affordable broadband Internet and LTE/5G connectivity for all Canadians. Under the terms of the agreement, the Government of Canada would provide a loan of $790 million and make a $650 million preferred equity investment in Telesat Lightspeed. In return, Telesat will commit to make certain minimum capital and operating expenditures in Canada in connection with the program and, in addition, to create hundreds of Canadian high-quality, full-time jobs and co-ops and provide academic scholarships. Through Telesat and its Canadian supply chain, the Telesat Lightspeed program is expected to support over 1,500 Canadian jobs, largely in STEM.
|
PCT | Hot Stocks10:05 EDT PureCycle, SK Global partner to open recycling plant in South Korea - PureCycle Technologies announced a signed memorandum of understanding with SK Global Chemical as a first step to enable the building and operating of a recycling facility in South Korea to transform polypropylene waste into ultra-pure polypropylene resin. The signed MOU will allow for PureCycle and SK Global Chemical to work toward solving the ongoing plastic waste crisis in South Korea and around the globe. The MOU with SK Global Chemical is designed to lead to the development of solvent-based recycling operations in Asia Pacific and add to the facility locations already growing across the United States. Construction on the flagship Ironton, Ohio recycling facility is well underway and expected to begin commercial production in the fourth quarter of 2022 and the company announced in July the location for the first cluster facility in Augusta, Georgia. PureCycle has already presold more than 20 years of UPRP output from the Ohio plant.
|
MGIC | Hot Stocks10:03 EDT Magic Software jumps as FY21 revenue outlook is again raised - Shares of Magic Software (MGIC) are climbing in morning trading after the global enterprise software company again raised its outlook for fiscal 2021 revenue. The company previously raised its revenue forecast in May. EARNINGS: For its second fiscal quarter, Magic Software said adjusted earnings per share was 23c and revenue was $119.2M, exceeding analysts' consensus estimates for 21c and $104.47M, respectively. Operating income for the quarter ended June 30 increased 29% to $12.7M compared to $9.8M in the same period last year, the company said. In a statement, CEO Guy Bernstein said: "Our solid execution in Q2 delivering double-digit growth across all key financial indices - revenues, gross profit, operating income, net income and EBITDA -, with record-breaking revenues reaching $119M and record-breaking operating income, demonstrate the important role Magic Software plays in its customers' lifecycles and transformative journeys, as well as the success of its strategy to build a broad business portfolio that creates value for our customers in managing, streamlining, accelerating and maximizing their businesses." REVENUE OUTLOOK AGAIN RAISED: The company raised its revenue guidance for fiscal 2021 to $450M-$460M from $425M-$435M, reflecting annual growth of 22.2%-23.9%. In May, Magic Software raised its revenue outlook from $420M-$430M. The current consensus estimate for FY21 revenue is $432.67M. DIVIDEND DECLARATION: In accordance with its dividend distribution policy, the company's board of directors declared a semi-annual cash dividend in the amount of 23.4c per share and in the aggregate amount of approximately $11.5M, reflecting approximately 75% of its distributable profits for the first half of 2021. The dividend is payable in U.S. dollars on September 14 to all of the company's shareholders of record at the close of trading on the NASDAQ Global Select Market and the Tel Aviv Stock Exchange on August 30. PRICE ACTION: In early trading, shares of Magic Software are up 10% to $19.12.
|
AMZN | Hot Stocks10:01 EDT Amazon on pace to buy over $120B of supplies, services from U.S. businesses - Amazon is on pace to spend over $120B on supplies and services from businesses in the U.S. in 2021, the company said in a statement. The purchases are from more than 200,000 companies that operate in communities across the country, from electric vehicle manufacturers to cardboard box producers to construction and engineering firms, it said. The 2021 spending represents an increase of 20% year over year and does not include any of the products Amazon buys and sells to customers in its stores, Amazon added.
|
BTCM | Hot Stocks10:00 EDT BIT Mining Limited falls -10.8% - BIT Mining Limited is down -10.8%, or -94c to $7.74.
|
BEKE | Hot Stocks10:00 EDT KE Holdings falls -13.6% - KE Holdings is down -13.6%, or -$2.69 to $17.18.
|
FOA | Hot Stocks10:00 EDT Finance of America falls -13.9% - Finance of America is down -13.9%, or -94c to $5.79.
|
DOCS | Hot Stocks10:00 EDT Doximity rises 10.3% - Doximity is up 10.3%, or $7.28 to $77.69.
|
CANO | Hot Stocks10:00 EDT Cano Health rises 10.6% - Cano Health is up 10.6%, or $1.13 to $11.79.
|
HIMS | Hot Stocks10:00 EDT Hims & Hers rises 16.4% - Hims & Hers is up 16.4%, or $1.24 to $8.81.
|
BTCM | Hot Stocks09:47 EDT BIT Mining Limited falls -9.7% - BIT Mining Limited is down -9.7%, or -84c to $7.84.
|
FOA | Hot Stocks09:47 EDT Finance of America falls -10.4% - Finance of America is down -10.4%, or -70c to $6.02.
|
TSLA | Hot Stocks09:47 EDT Musk says Tesla makes China cars for export in quarter's first half, then local - In a reply to a tweet from Ark Invest's Cathie Wood, Tesla CEO Elon Musk stated: "Tesla makes cars for export in first half of quarter & for local market in second half. As publicly disclosed, we are operating under extreme supply chain limitations regarding certain "standard" automotive chips. Most problematic by far are Renesas & Bosch." Reference Link
|
BEKE | Hot Stocks09:47 EDT KE Holdings falls -15.6% - KE Holdings is down -15.6%, or -$3.11 to $16.77.
|
AZEK | Hot Stocks09:47 EDT Azek rises 9.7% - Azek is up 9.7%, or $3.65 to $41.15.
|
PLTR | Hot Stocks09:47 EDT Palantir rises 10.3% - Palantir is up 10.3%, or $2.31 to $24.66.
|
HIMS | Hot Stocks09:47 EDT Hims & Hers rises 18.8% - Hims & Hers is up 18.8%, or $1.42 to $8.99.
|
TIG | Hot Stocks09:35 EDT Trean Insurance Group Inc trading resumes
|
AMBA | Hot Stocks09:33 EDT KeepTruckin selects Ambarella CV22 CVflow edge AI vision SoC for AI Dashcam - Ambarella and KeepTruckin announced that KeepTruckin selected Ambarella's CV22 CVflow edge AI vision system on chip for its new AI Dashcam. This latest AI Dashcam uses a single CV22 SoC to simultaneously provide AI and image processing for its dual-camera system, which integrates one camera for the front advanced driver assistance system with incident recording, and a second RGB-IR camera for the driver-monitoring system with driver recording. Additionally, with Ambarella's edge AI processing performance-per-watt, the CV22 enables the AI Dashcam to run KeepTruckin's proprietary AI algorithms for real-time high-risk behavior detection and active warnings directly on the small form factor device, with minimal heat dissipation.
|
TIG | Hot Stocks09:30 EDT Trean Insurance Group Inc trading halted, volatility trading pause
|
TRNO | Hot Stocks09:29 EDT Terreno Realty acquires three industrial properties in Seattle for $50M - Terreno Realty acquired three industrial properties in Seattle, Washington for a purchase price of approximately $50M.
|
TARS | Hot Stocks09:24 EDT Tarsus Pharmaceuticals appoints Rosemary Crane to board of directors - Tarsus Pharmaceuticals announced the appointment of Rosemary Crane to its Board of Directors. Crane will serve as the Chair of the newly created Science and Technology Committee, focused on external and internal innovation and pipeline opportunities. Crane has more than 30 years of extensive experience in the pharmaceutical industry, including executive leadership, board service, innovation, business development, operations, and global commercialization expertise. Crane currently sits on the boards of Teva Pharmaceuticals Industries and Catalent, as well as acts as a director of the Hackensack Meridian Health Center for Discovery and Innovation.
|
MTBC | Hot Stocks09:24 EDT CareCloud announces signing of client for medSR division - CareCloud is proud to announce that its newly formed medSR division is proving to be an integral partner to medical groups needing the right mix of people, processes and technology to optimize performance. medSR is a subsidiary of CareCloud that offers in-depth knowledge and experience in planning and executing transformational projects, providing a full suite of consulting solutions that address clients' biggest technology and staffing challenges across business intelligence, analytics, technology planning and transformation, interoperability, integration, regulatory compliance, and performance improvement. medSR recently marked a significant milestone in signing its first new client to integrate its consulting services with CareCloud Force, a service to extend administrative and back-office support functions.
|
ANF | Hot Stocks09:22 EDT abercrombie kids renews 'Kind Crew' digital series for second season - abercrombie kids has renewed its popular "Kind Crew" digital series for a second season, which is available now exclusively on Nickelodeon's YouTube channel. The series continues to help inspire young people to make the world a more compassionate, understanding and kind place. It will feature a new cast of four phenomenal kids as well as special guests who can speak to important topics at hand - such as returning to school, how to leverage your uniqueness as your "superpower" and more
|
FMCC | Hot Stocks09:18 EDT Freddie Mac prices $741M multifamility K-Deal, K-744 - Freddie Mac recently priced a new offering of Structured Pass-Through Certificates, which are backed by underlying collateral consisting of fixed-rate multifamily mortgages with predominantly 7-year terms. The company expects to issue approximately $741 million in K Certificates, which are expected to settle on or about August 19, 2021.
|
CMTL | Hot Stocks09:18 EDT Comtech gets $3.6M in multiple contracts from a U.S. system integrator - Comtech Telecommunications announced that during its fourth quarter of fiscal 2021, it was awarded multiple contracts aggregating $3.6M from a U.S. system integrator for X-band SSPAs and BUCs for transportable satellite communication terminals. "Comtech's SSPAs and BUCs have a proven heritage across multiple military systems and operate with high reliability in certified terminals around the globe," said Fred Kornberg, Chairman of the Board and Chief Executive Officer of Comtech Telecommunications Corp. "We are pleased with the ongoing success of these transportable terminals."
|
BDRBF | Hot Stocks09:18 EDT Bombardier announces closing of new issuance of senior notes - Bombardier announced that it has successfully closed its previously announced offering of $750,000,000 aggregate principal amount of Senior Notes due 2028. The New Notes carry a coupon of 6.000% per annum, mature on February 15, 2028 and were sold at 100.000% of par. Bombardier intends to use the net proceeds of this offering of New Notes, together with cash on hand, for the repayment and/or retirement of outstanding debt, including to redeem all of its outstanding 6.000% Senior Notes due October 2022, of which there is $514 million aggregate principal amount outstanding on the date hereof, and all of its outstanding 6.125% Senior Notes due 2023, of which there is $534 million aggregate principal amount outstanding on the date hereof, for related fees and expenses and for other general corporate purposes.
|
CSSE | Hot Stocks09:17 EDT Chicken Soup says Going From Broke exceeds 5M views on Crackle - Chicken Soup for the Soul Entertainment announced that Going From Broke, the award-winning Crackle original series from executive producers Ashton Kutcher and Chicken Soup for the Soul Entertainment, has driven over 5 million total views since the May 20th launch of season 2.
|
GTEH | Hot Stocks09:16 EDT GenTech appoints Vista Brands to drive sales growth - GenTech Holdings is excited to announce that it has hired outsourced sales agency Vista Brands to drive a widened distribution footprint and expanded sales for GenTech's newly acquired product lines, Fizzique and MPB Snacks.
|
EVRI PENN | Hot Stocks09:15 EDT Everi, Penn National to launch digital CashClub Wallet at Penn National casinos - Everi Holdings (EVRI) announced that the Company's digital CashClub Wallet technology is powering Penn National Gaming's (PENN)) new mychoice Wallet at Hollywood Casino York in Pennsylvania, following previous installations at Hollywood Casino at Penn National Race Course and the Meadows Racetrack & Casino in Pennsylvania. The new mychoice Wallet provides Penn National's guests with a secure, convenient cashless payment method on the casino floor, and this installation is part of an agreement that will see mychoice Wallet introduced at Penn National's casino properties pending appropriate regulatory approvals. Everi's CashClub Wallet is a mobile digital wallet that enables casino operators to offer cashless and contactless funding of electronic game play across the casino floor. Penn National's mychoice Wallet, powered by Everi, will allow guests to deposit funds into their digital wallet at their convenience - at any time or anywhere, including before arriving at the property or while at the property via a debit card, credit card or directly from their bank account. Guests can then access these funds for use directly at the game, creating a fully cashless, contactless environment that leverages the guest's mobile device. On the casino floor, mychoice Wallet will interface with the Foundation casino management system from Acres Manufacturing, which provides for direct interaction with all of the slot machines and table games, while also providing instantaneous sharing of slot player data across Penn National's casinos. At the conclusion of game play, CashClub Wallet technology enables guests to move funds back into their digital wallet where they can be held for future use or electronically sent back into a bank account. Players can store multiple payment methods and easily move funds in and out of the casino. Everi's CashClub Wallet technology supports responsible gaming through spending limit management.
|
COO | Hot Stocks09:14 EDT Cooper Companies announces MiSight approval in China - CooperCompanies announced that the Chinese National Medical Products Administration, which regulates medical devices and pharmaceuticals in China, has approved CooperVision MiSight 1 day contact lenses for use within the country following a priority review. "We are extremely excited to receive this approval," said Al White, President and CEO. "The increasing incidence of myopia is one of the most pressing global eye-health issues we face today, and receiving approval from the NMPA allows us to work closely with eye-care professionals proactively treating children in China. MiSight(R) is the most innovative contact lens in the market, and we remain incredibly passionate about promoting it along with our ortho-k and SightGlass Vision(R) myopia management products."
|
TMTS | Hot Stocks09:14 EDT NextNav launches Unreal Engine plug-in integrating vertical location services - NextNav announced the release of its Unreal Engine plug-in, integrating its vertical positioning service, Pinnacle. Now, developers can unlock 3D geolocation and z-axis across all games and applications built with the Unreal Engine. The launch of the plug-in comes weeks after the company received an Epic MegaGrant, which it will use to bring its vertical location capabilities to the Unreal Engine. The plug-in delivers precise altitude data, allowing developers to integrate vertical location into any geolocation application built with the Unreal Engine, Epic Games' real-time 3D tool for creating cutting-edge content and immersive experiences. Specifically, the plug-in unlocks new possibilities for augmented experiences in urban areas - which represent a largely underutilized market for location-based gaming, architectural and automotive visualization, among many other applications. "We are setting a new standard for immersive, location-based experiences built on the Unreal Engine," said NextNav CEO Ganesh Pattabiraman. "From manufacturing and training applications to a wide variety of games, our vertical location data, with floor level accuracy, can help creators expand their universes, reimagine the next generation of digital experiences, and delight end-users." In June, NextNav entered into a definitive merger agreement with Spartacus Acquisition Corporation in a transaction that would result in NextNav being listed on the Nasdaq. The transaction is expected to close late in the third quarter of 2021 or early in the fourth quarter of 2021, subject to satisfaction of customary closing conditions.
|
IPIX | Hot Stocks09:10 EDT Innovation announce last patient visit completed in Phase 2 trial of Brilacidin - Innovation Pharmaceuticals provided additional information regarding the status of its randomized, double-blind, placebo-controlled Phase 2 clinical trial of Brilacidin for the treatment of moderate-to-severe COVID-19 in hospitalized patients. The company is developing Brilacidin for treatment of COVID-19 under U.S. FDA Fast Track designation. Full enrollment in the 120-patient clinical trial was completed in early June 2021. The last patient follow-up visit occurred on July 30, 2021. The subject database remains blinded with the current emphasis on confirmation of all data entered at study sites, as well as completion of source data verification and the necessary checks and reviews by the data management vendor in preparation of database lock. Following database lock and transfer to the biostatistics vendor, analysis of the unblinded data from the clinical trial will begin to assess Brilacidin's performance, against placebo, across primary, secondary, and other endpoints. Topline results are anticipated to be available one week after database lock, with full analysis to follow.
|
API | Hot Stocks09:09 EDT Agora selected by De Kabeza for real-time customer engagement - Agora announced a partnership with live mobile game company De Kabeza to bring real-time engagement to their platform. The collaboration integrates Agora's voice, video, messaging, and interactive live streaming technology into the company's production tools. Through the partnership, De Kabeza aims to empower its customers, like Sorteos Tec which runs lottery games to raise money for university scholarships, to create new experiences and attract new audiences. Agora's technology embeds into De Kabeza's platform, which creates a low-latency experience that enables De Kabeza's clients to have real-time experiences via two-way communications between the host and viewers.
|
JAKK | Hot Stocks09:09 EDT JAKKS Pacific's Disguise unit renews North American rights for Sesame Street - Disguise, a costume company, and a division of toy and consumer products manufacturer JAKKS Pacific announced a renewal of its North American rights for the iconic series Sesame Street. Disguise will continue to design, market, manufacture and distribute costumes, costume accessories and trunk-or-treat kits featuring new and classic Sesame Street characters. Sesame Street has been on air for 52 years making it one of the longest running shows in American history. Disguise celebrates its 35th Anniversary in 2022 and has held the Sesame Street license for 31 years. It was one of the very first licenses acquired by the company. Disguise will be introducing new segments, including adaptive costumes and wheelchair wraps to support the strong message of diversity and inclusivity that Sesame Street so proudly teaches.
|
PGNY | Hot Stocks09:08 EDT Progyny offers paid pregnancy loss leave to its employees - Progyny announced a pregnancy loss leave benefit for all employees effective immediately. The five-day paid leave is an enhancement to its bereavement leave policy. "I personally know friends, family, and colleagues who have experienced pregnancy loss. One in four pregnancies end in a loss, so we all have someone in our lives who has gone through this, whether we know it or not. Grieving employees are often left to push through and take their own paid time off in order to recover properly," said Jennifer Bealer, General Counsel at Progyny. "In a recent study, after a pregnancy loss, nearly a third of women suffered post-traumatic stress, while one in four experienced moderate to severe anxiety. We have to recognize the importance of mental health, especially in these critical moments." The pregnancy loss leave will cover full-time and part-time employees, their spouse's, registered domestic partner's, or their surrogate's loss of pregnancy due to pregnancy termination or miscarriage. The policy also includes failed adoption matches, adoptions that do not finalize due to legal contestation, or failed surrogacy arrangements. Leave for employees who experience a still birth is already provided under Progyny's existing disability and paid family leave policies.
|
EVRI PENN | Hot Stocks09:06 EDT Everi Holdings, Penn National to launch digital CashClub Wallet technology - Everi Holdings (EVRI) announced that the company's digital CashClub Wallet technology is powering Penn National Gaming (PENN) new mychoice Wallet at Hollywood Casino York in Pennsylvania, following previous installations at Hollywood Casino at Penn National Race Course and the Meadows Racetrack & Casino in Pennsylvania. The new mychoice Wallet provides Penn National's guests with a secure, convenient cashless payment method on the casino floor, and this installation is part of an agreement that will see mychoice Wallet introduced at Penn National's casino properties pending appropriate regulatory approvals.
|
CLEU | Hot Stocks09:06 EDT China Liberal Education to provide management solution to kindergarten in China - China Liberal Education entered into a strategic cooperation agreement with Boya Shoushan Kindergarten, a kindergarten in Cangshan District of Fuzhou City, on August 11. The company agrees to provide Boya with comprehensive smart kindergarten solutions including data management and kindergarten facility reconstruction. The company builds a unified platform to collect the underlying data of all aspects of the kindergarten management to gather integrated information on children's attendance, class management, material use, fee collection and refund, faculty management, and kindergarten operations.
|
VZ EQIX | Hot Stocks09:06 EDT Verizon expands global automation capabilities with Equinix - Verizon Business (VZ) is expanding its Software-Defined Interconnect solution, enabling global enterprise and Public Sector customers to connect their MPLS and Ethernet private networking services to cloud, infrastructure and service providers with same-day connectivity. Together with Equinix (EQIX), the two companies worked to expand this solution to meet changing global needs. The SDI solution is part of the Verizon Business Network-as-a-Service strategy. "Organizations are seeking more agile ways of working from anywhere on any device. To take advantage of new solutions built on 5G, from real-time data analytics and AI, to enhanced security and AR/VR, they need a flexible, programmable, scalable and reliable platform that delivers network services in a much more resilient and cloud-centric way than traditional network infrastructures," said Massimo Peselli, Senior Vice President of Global Enterprise, Verizon Business. "Equinix is a trusted strategic partner who helps enable our Network-as-a-Service approach to managed services, and this SDI expansion provides our customers with the agility they need to meet their needs as they migrate to the cloud."
|
ANF | Hot Stocks09:05 EDT Abercrombie & Fitch, Zappos.com announce partnership - Zappos.com and Abercrombie & Fitch announced a partnership to bring Abercrombie & Fitch apparel to a larger U.S. consumer base through Zappos.com. Beginning August 16, customers can shop Zappos for Abercrombie & Fitch favorites, including Abercrombie's high-quality, size-inclusive denim and essential tops for adults and kids. Through this partnership, which is the first of its kind in the U.S. for Abercrombie & Fitch, the two brands also teamed up to create an exclusive footwear capsule available only on Zappos.com and Abercrombie.com, featuring a wide range of sizes and designed to perfectly style with Abercrombie & Fitch denim fits.
|
PPG | Hot Stocks09:04 EDT PPG commences operations in Morocco sealant facility - PPG announced the startup of a facility in Tangier, Morocco, that will produce automotive sealants for local vehicle production. The plant, which marks the company's first automotive coatings production facility in Africa, initially will supply materials for Renault Group's Dacia brand vehicles that are produced in Tangier and Casablanca.
|
ARGO | Hot Stocks09:04 EDT Argo Group announces Susan Comparato as Chief Administrative Officer - Argo Group International Holdings announced several notable leadership appointments with a focus on simplifying the organization. "This is the natural next step in our continuing evolution as a leading U.S.-focused specialty insurer," said Argo Group CEO Kevin Rehnberg. "These organizational changes will help continue and even accelerate our progress against our strategic goals. Our recent earnings results demonstrate the good progress we are making, and these appointments will further streamline our structure." The company announced that Susan Comparato, chief administrative officer - In this role, Comparato will oversee the global business services and innovation teams; the U.S. transformation team, which is focused on aligning the business with a significant technology program of work; group communications; and group enterprise security. Comparato has formerly served as Argo's U.S. general counsel and most recently managed a portfolio of Argo's U.S. business lines.
|
ORBC | Hot Stocks09:03 EDT Farmbot selects ORBCOMM's satellite IoT technology - ORBCOMM announced that Farmbot Monitoring Solutions has selected ORBCOMM's satellite IoT technology to enable their smart agriculture solutions, which help farmers improve the visibility and management of their water resources. Farmbot's solution is powered by ORBCOMM's global satellite OGi modem and Inmarsat's L-band connectivity to deliver remote monitoring of farm water supplies, including tanks, dams and reservoirs, and capturing images in real-time. Farmbot's solution integrates with a wide range of sensors and an optional wired camera to deliver valuable reports and trend analysis on water, diesel and trough levels, rainfall, flow and pressure rates, alerts for valve leaks or pump issues, livestock drinking habits along with staff movements using a safety-check-in module. The ORBCOMM-enabled solution has been designed to withstand remote and harsh climates and works across the entire Australian continent. "We're excited to partner with Australian agritech company Farmbot on helping farmers throughout the continent automate their farming processes and gain significant savings in time and money," said Christian Allred, ORBCOMM's Executive Vice President of Global Sales. "By leveraging our state-of-the-art modem and Inmarsat's ubiquitous L-band satellite connectivity, Farmbot can provide its customers with actionable data and key business insights to better manage their water supplies and create a safer, more profitable and sustainable farm operation, which is an important priority in our corporate social responsibility efforts."
|
NUE BA | Hot Stocks09:03 EDT Nucor elects Norma Clayton to board of directors - Nucor (NUE) announced that on August 11, its Board of Directors elected Norma Clayton as a director, effective September 1. Clayton most recently served as Vice President for Learning, Training and Development at The Boeing Company (BA) from July 2007 until her retirement in March 2016.
|
EVRG | Hot Stocks09:03 EDT Evergy appoints Lesley Elwell aschief human resources officer - Evergy announced Lesley Elwell will join the company as senior VP and chief human resources officer. In this role, Elwell will lead Evergy's human resources organization, with an emphasis on talent strategy, employee engagement, organizational development and performance management. She will report to David Campbell, Evergy's president and CEO. Elwell joins Evergy with more than 25 years of experience holding human resources and operations leadership roles for large, publicly traded companies in consumer and business-to-business industries. Currently she serves as chief people officer at Kansas City-based JE Dunn.
|
GDDY | Hot Stocks09:02 EDT GoDaddy authorizes $250M accelerated share repurchase plan - GoDaddy has entered into an accelerated share repurchase agreement with Goldman Sachs to repurchase $250M of GoDaddy's common stock. The ASR was entered into pursuant to GoDaddy's share repurchase program, under which approximately $750M share repurchase authorization will remain available upon completion of the ASR. Following completion of the program, GoDaddy will have repurchased a total of approximately 6.9 million shares year-to-date, representing 4% of total shares outstanding. Since January 2020, GoDaddy will have repurchased approximately 16.9 million shares, representing more than 9% of total shares outstanding. The final settlement of the ASR is expected to be completed in Q3 of 2021.
|
PEG | Hot Stocks08:57 EDT PSEG to sell fossil generating portfolio to ArcLight Capital for $1.92B - Public Service Enterprise Group has entered into an agreement to sell its 6,750-megawatt fossil generating portfolio to newly formed subsidiaries of ArcLight Energy Partners Fund VII, L.P., a fund controlled by ArcLight Capital Partners, for aggregate consideration of approximately $1.92B, subject to customary adjustments, and is expected to be completed late in the fourth quarter of 2021 or the first quarter of 2022. Together with the sale of its Solar Source assets in June, PSEG is anticipating to receive approximately $2.15B of after-tax net proceeds. The sale of PSEG Fossil, part of PSEG's Strategic Alternatives process announced in July 2020, comprises 13 generation units in New Jersey, Connecticut, Maryland and New York. The transactions are subject to the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976; approval by the Federal Energy Regulatory Commission and certain state regulatory bodies; and other customary closing conditions. In connection with the transaction, beginning in the third quarter of 2021, the assets and liabilities of PSEG Fossil will be classified as assets held for sale. As a result, PSEG expects to record a pre-tax impairment charge of approximately $2.150B-$2.225B, employee severance and retention costs up to $25M, debt redemption costs including a make-whole premium of approximately $280M-$340M, and potential impacts on employee pension and other post retirement plans, environmental remediation costs and other items.
|
KPTSF | Hot Stocks08:57 EDT KP Tissue sees Q3 adjusted EBITDA to be in range higher than Q2 - The company said, "We are beginning to see the risks and uncertainties associated with COVID-19 subside and expect to see activities and behaviour start to return to more pre-COVID levels in the second half of 2021, in both the Consumer and Away-From-Home segments. Despite higher pulp prices, we expect Q3 2021 Adjusted EBITDA to be in a range which is higher than Q2 2021 and lower than Q3 2020."
|
OLLI | Hot Stocks08:56 EDT Ollie's Bargain Outlet announces Senior VP of Supply Chain leaving company - Ollie's Bargain Outlet announced that Ray Daugherty, Senior Vice President of Supply Chain, will be leaving the company effective August 27th, to pursue other interests. The company has commenced its search for a new Head of Supply Chain. Eric van der Valk, Executive Vice President and Chief Operating Officer, will lead this function until a replacement is named.
|
ATAI | Hot Stocks08:55 EDT Atai Life Sciences launches Revixia Life to develop SalA - atai Life Sciences announced the launch of Revixia Life Sciences, a wholly owned subsidiary developing Salvinorin A to treat a variety of mental health disorders. Derived from Salvia divinorum, SalA is a unique non-nitrogenous agonist of the kappa-opioid receptor with potential use in treatment-resistant depression, substance use disorder and pain. Traditionally, Salvia divinorum has been used by the Mazatec people in Oaxaca, Mexico for a variety of illnesses, such as diarrhoea, headaches and rheumatism, as well as for palliative care. Clinically, there are published reports of the potential benefits of Salvia divinorum in the treatment of TRD. "In exploring SalA, Revixia aims to develop a product with a differentiated pharmacological and treatment effect. Considering the significance of prior evidence in humans in parallel with the substantial unmet need in TRD, we believe Revixia has high commercial potential and an increased probability of success in the clinic," said Florian Brand, CEO and co-founder of atai Life Sciences. "SalA is a great product candidate that magnificently matches the criteria we strive for, with recognized synergies across the atai platform." Development is underway with clinical trials expected to begin in the second half of 2022.
|
MIGI CAN | Hot Stocks08:54 EDT Mawson Infrastructure purchases additional 17,352 bitcoin miners from Canaan - Mawson Infrastructure (MIGI) announced it has purchased an additional 17,352 of Canaan's (CAN) latest generation ASIC bitcoin miners, adding over 1.5EH to Mawson's existing operations. The additional 17,352 latest generation Avalon A1166 and A1246 bitcoin miners will be deployed across Mawson's U.S.and Australian operations in 2021 and 2022, with miners to be deployed at the company's first Australian site in Q4, as well as at its facility in Georgia.
|
GLUE | Hot Stocks08:54 EDT Monte Rosa Therapeutics announces upcoming milestones - Development candidate selection for lead program targeting GSPT1 for the treatment of cancers overexpressing one of the Myc family genes. The company anticipates selecting a development candidate and advancing it into IND-enabling studies before year-end. Progression of at least one program in addition to NEK7 into lead optimization by end of 2021.
|
GLUE | Hot Stocks08:53 EDT Monte Rosa Therapeutics expects cash to fund operations into late 2024 - Cash and cash equivalents as of June 30, 2021, were $357.1 million, compared to $41.7 million as of December 31, 2020. The June 30th balance does not include the additional $31.0 million in net proceeds the company received as part of its initial public offering from the full exercise of the underwriters' option to purchase up to an additional 1,755,000 shares of common stock at the public offering price of $19.00 per share. The company expects its cash and cash equivalents , including the aggregate net proceeds from the initial public offering, will be sufficient to fund our planned operations and capital expenditures into late 2024.
|
DPRO | Hot Stocks08:53 EDT Draganfly launches North American manufactured drone - Draganfly announced that it is launching its new, North American designed and built, Draganflyer Commander2 drone system. The new Draganflyer Commander2 system has been exclusively designed, developed, and manufactured in Canada, and fully complies with "Built-in-North America" requirements to take advantage of federal regulatory requirements concerning the origin and security of drone systems and devices. The Draganflyer Commander2 is a small Unmanned Aerial System. Cory Baker is Draganfly's Production Manager: "Integrity and data security are of the highest importance to Draganfly's clients, and the improved Commander platform delivers in those key areas. Shifts in federal requirements have also made commercial users reconsider their UAV needs, and Commander2 has the solutions to answer that demand."
|
MDXG | Hot Stocks08:51 EDT MiMedx promotes Marion Snyder to Chief of Staff, Senior VP, Government Affairs - MiMedx announced the promotion of Marion Snyder to Chief of Staff, Senior Vice President, or VP, Government Affairs. As a member of the Senior Leadership Team, Snyder will oversee strategic projects requiring cross-functional input, and drive the integration, effectiveness, and efficiency of decision making throughout the organization to advance multiple, company-wide initiatives. She will continue in her role as co-chair of the company's Inclusion and Diversity Council and serve as an important voice for MIMEDX's government affairs and patient advocacy efforts. As a policy contributor and trusted advisor, she will serve as a significant communications link with the broader organization as a whole. With this promotion, the Company has commenced an executive search to fill Snyder's prior role of Senior Vice President, Market Access.
|
NFYEF | Hot Stocks08:50 EDT NFI Group, Robotic Research enter agreement to increase ADAS deployment - NFI Group announced an agreement with Robotic Research to increase the deployment of advanced driver-assistance systems in transit agency fleets across North America. The agreement expands the partnership between New Flyer of America and Robotic Research originally announced in 2019, and builds on the unveiling of North America's first automated transit bus, the Xcelsior AV, to pursue integration of Robotic Research's AutoDrive technology into new and existing public transit vehicles. The technology, which will incorporate Society of Automotive Engineers Standard J3016 capabilities up to Level 4, will add ADAS features to help prevent pedestrian and cyclist collisions. Ultimately, automated vehicles ("AVs") will contribute to improving road safety and lending the potential to shorten commute times, increase energy efficiency, and reduce congestion.
|
HBM | Hot Stocks08:49 EDT Hudbay Minerals achieves first gold production at New Britannia mill - Hudbay Minerals announced that gold production has commenced at the New Britannia mill in Snow Lake, Manitoba. Refurbishment activities at the gold mill were completed in June 2021, followed by commissioning and startup activities in July. The mill achieved first gold production on August 11, 2021, in line with the timelines assumed in recent company guidance and ahead of the original schedule to produce first gold before the end of 2021. "We are proud of the New Britannia project and operating teams for completing construction activities ahead of the original timelines and achieving a successful ramp up to first gold pour," said Peter Kukielski, Hudbay's President and Chief Executive Officer. "This is a major growth milestone for Hudbay and our Manitoba business as it marks the beginning of the transition of our Lalor mine to a primary gold operation." The company is also completing the construction of a new copper flotation facility at New Britannia, which remains on track for commissioning and ramp up in the fourth quarter of 2021.
|
TRP | Hot Stocks08:48 EDT TC Energy, Irving Oil enter MOU to explore series of energy projects in Canada - TC Energy Corporation and privately held Irving Oil have signed a memorandum of understanding to explore the joint development of a series of proposed energy projects focused on reducing greenhouse gas emissions and creating new economic opportunities in New Brunswick and Atlantic Canada. Together, the two energy companies have identified a series of potential projects for exploration focused on decarbonizing current assets and deploying emerging technologies to reduce overall emissions. The partnership's initial focus will consider a suite of upgrade projects at Irving Oil's refinery in Saint John, New Brunswick, with the goal of significantly reducing emissions through the production and use of low-carbon power generation. The partnership will also explore opportunities that will aid in decarbonizing local industry over the medium- and long-term time horizons via the production and distribution of low emission hydrogen, coupled with a world class carbon capture and sequestration network. The partnership will target industry solutions that will lower the emissions in the region to align with carbon reduction goals and enhance the opportunities for future development in Atlantic Canada.
|
NOC SWK | Hot Stocks08:48 EDT Northrop Grumman appoints Graham Robinson to board of directors - Northrop Grumman (NOC) announced it has elected Graham Robinson to its board of directors. Robinson is the senior vice president and president of STANLEY Industrial, a business segment of Stanley Black & Decker (SWK), a position he has held since April 2020.
|
BHP | Hot Stocks08:47 EDT Midland provides update on exploration work under BHP Group strategic alliance - Midland Exploration is pleased to provide an update on a major exploration program underway for nickel in Nunavik. The 2021 program is carried out under the strategic alliance concluded in August 2020 between Midland's wholly owned subsidiary, Midland Base Metals, and Rio Algom Limited, wholly owned subsidiary of BHP Group. Highlights: High-quality ground electromagnetic survey conducted on the Papavoine Ni-Cu-Co prospect. 3D modelling of the Papavoine prospect underway, integrating new ground geophysics and historical drilling data to identify new drilling targets. Airborne electromagnetic surveys totalling nearly 5,000 line kilometres completed in areas deemed favourable for Ni-Cu-Co mineralization. Prospecting and mapping campaign scheduled in September, targeting high-priority electromagnetic anomalies identified in the airborne survey as well as Ni-Cu-Co showings identified in 2020. The Alliance with BHP for nickel exploration is mainly focused on mafic intrusive rocks with troctolite/olivine gabbro compositions similar to those in Voisey's Bay and the Nain Province, but that have historically received far less exploration, despite the discovery of several Ni-Cu-Co prospects and occurrences. The Papavoine Ni-Cu-Co prospect, discovered in 2000 and currently held by Midland, graded up to 0.63% Ni, 0.31% Cu and 0.04% Co over 6.6 metres in channel samples. Approximately 20 kilometres southeast of Papavoine, the Mantas intrusion yielded grades up to 0.48% Ni, 0.21% Cu and 0.06% Co over 0.7 metre. In 2020, work by Midland and BHP also confirmed two additional areas with strong potential. The Bonne Une troctolite intrusion graded up to 0.23% Ni and 0.23% Cu in grab samples. In the A1 area, eight mineralized boulders, locally derived but the source of which has yet to be determined, graded more than 0.1% Ni, with a highest grade of 0.14% Ni and 0.16% Cu in grab samples. Note that grades obtained in grab samples are not representative of mineralized zones. A high-quality Squid-type ground electromagnetic survey was recently completed to cover part of the olivine gabbro/troctolite intrusion that hosts the Papavoine Ni-Cu-Co prospect. Although its exact dimensions have not yet been determined, the intrusion is more than 500 metres thick and covers a surface area of at least 2 kilometres by 1.5 kilometres. Seven historical drill holes completed in 2001 in a section of the Papavoine intrusion identified, at its base, a laterally continuous zone of rocks characterized by chaotic textures and anomalous Ni-Cu-Co sulphide contents over several tens of metres in thickness. Given the shallow dip of the Papavoine intrusion, the base of the intrusion remains at relatively shallow depths over an extensive surface area, which provides a clear advantage for exploration. These new high-quality geophysical data from the Papavoine area are currently being integrated into a 3D model along with geological and geochemical data from the 7 historical drill holes completed in 2001 in a section of the intrusion, in an effort to identify new high-potential drilling targets at the base of this intrusion. This work is considered additional accelerated work designed to assess the possibility of transferring existing Midland projects to the Alliance designated project category. Several high-quality VTEM-type airborne electromagnetic surveys were completed in recent months to cover areas deemed favourable for nickel exploration. These VTEM surveys total nearly 5,000 line kilometres. Several new high-priority electromagnetic anomalies were identified and will be followed up by prospecting and field mapping starting mid September. The prospecting campaign will also target Ni-Cu-Co showings identified during the 2020 prospecting campaign. A budget of $1.3 million was allotted for the prospecting campaign and VTEM surveys. An additional budget of $600,000 was also approved for the ground electromagnetic survey and 3D modelling of the Papavoine intrusion.
|
VZ AMCX | Hot Stocks08:47 EDT Verizon's new customers to get 12 months of AMC+ - New customers who purchase a smartphone on a new line with select Verizon (VZ) Unlimited plans, can receive up to 12 months of AMC+ (AMCX) - the streaming home of hit shows like The Walking Dead and exclusive content from Shudder, Sundance Now, IFC Films and BBC America. "Enhancing the way that fans enjoy their beloved content is at the center of what we do at Verizon," says Erin McPherson, Head of Content Partnerships at Verizon. "Adding up to 12 months of AMC+ on us to our robust set of content offerings is just one more way we're able to give our customers unique experiences, like getting to see the new season of the iconic AMC show, The Walking Dead, and the wealth of other acclaimed content that AMC+ offers, all on us." AMC+ is a premium streaming bundle that delivers popular shows and critically-acclaimed original programming from AMC, BBC America, IFC and SundanceTV, as well as the complete library of more entertainment from Shudder, Sundance Now and IFC Films Unlimited.
|
MEDXF | Hot Stocks08:44 EDT Medexus Pharmaceuticals completes enrollment in Phase 4 trial of IXINITY - Medexus Pharmaceuticals announced that is has completed enrollment in its Phase 4 Clinical Trial of IXINITY, targeting label expansion for pediatric hemophilia B patients. The Trial is investigating IXINITY as a prophylactic treatment for pediatric patients under 12 years of age with hemophilia B, a hereditary bleeding disorder characterized by a deficiency of clotting factor IX. IXINITY is currently an FDA approved intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with hemophilia B. Medexus has now enrolled its last patient in this Phase 4 Clinical Trial, with the trial expected to be complete in June 2022. On completion, the Company believes this study may support an expansion of the indicated patient population for IXINITY. According to the World Federation of Hemophilia 'Report on the Annual Global Survey 2017,' approximately 1 in 3 patients treated for hemophilia B in the U.S. are 12 years of age or younger.
|
IDT | Hot Stocks08:43 EDT BOSS Revolution accelerates network expansion through partnership with TerraPay - BOSS Revolution Money Transfer, the international remittance service of IDT, announced a partnership with TerraPay, a global payments infrastructure company, to provide BOSS Revolution customers with new money transfer destinations across Africa, Asia, LATAM and Europe. BOSS Revolution has begun offering secure payments to mobile wallets in Senegal and Benin through TerraPay to begin the expansion. "Our customers in the US can now send money to friends and family in Senegal, Benin and 36 other countries including over 309,000 points of payment," said Alfredo O'Hagan, IDT's SVP for Consumer Payments. "We are delighted to partner with TerraPay as we open new corridors and emphasize real-time payment options leveraging their extensive platform."
|
WDOFF | Hot Stocks08:43 EDT Wesdome Gold Mines commences trading on OTCQX market - Wesdome Gold Mines announces that its common shares are now trading on the OTCQ(R) under the ticker symbol WDOFF, after qualifying for an upgrade from the Pink market. The OTCQX Best Market is the highest market tier of OTC Markets on which 11,000 U.S. and global securities trade. Wesdome common shares will continue to trade on the TSX under the symbol WDO as the Company's primary listing. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the Company at www.otcmarkets.com.
|
XSPA | Hot Stocks08:41 EDT XpresSpa announces agreement with 98point6 as Treat Partner for virtual care - XpresSpa announced an agreement with 98point6, an on-demand virtual primary care provider, to provide services for the new Treat Care app. The Treat Care app will soon be available in the Apple App Store and the Google Play Store and will offer travel health and wellness content, access to board-certified health professionals, a travel wallet to store health records and more. "This partnership with a telehealth industry leader, 98point6, will allow us to fuel an important component for one of the key features of our new app launch later this month," said Doug Satzman, XpresSpa Group CEO. "The Treat Care app will allow customers to securely communicate and video chat with providers instantly from anywhere at any time." 98point6 is an on-demand, text-based primary care service that delivers personalized diagnosis, treatment and consultation to patients across the country. 98point6 board-certified physicians will consult with Treat Care app users and diagnose and treat hundreds of conditions through secure in-app messaging and video conferencing. This service will be one of the benefits for Treat Members.
|
UAVS | Hot Stocks08:41 EDT Ageagle Aerial Systems announces dismissal of class action lawsuit - AgEagle Aerial Systems announced that multiple, previously-disclosed lawsuits against the Company and certain of its current and former officers and directors have been dismissed. As previously disclosed in the Company's SEC filings, AgEagle and certain of its current and former officers and directors were named as defendants in two putative securities class actions filed in the U.S. District Court for the Central District of California. These matters were consolidated, and a Lead Plaintiff designated by Court Order. The Company is now pleased to report that on July 30, 2021, the Lead Plaintiff filed a voluntary dismissal of the consolidated securities class action. Separately, two shareholders filed a derivative compliant on behalf of the Company and against certain of our current and former officers and directors before the Nevada federal court. AgEagle is pleased to report that on July 20, 2021, the Plaintiffs in this Nevada derivative action filed a voluntary dismissal of the action, and the court designated the case "closed" and "terminated." Finally, on July 27, 2021, a separate shareholder filed a similar derivative complaint on behalf of the Company and against certain of its current and former officers and directors in the U.S. District Court for the Central District of California. AgEagle is pleased to report that on August 11, 2021, the Plaintiff in this California derivative action filed a voluntary dismissal of the action. These dismissals resolve all known litigation against the Company and its officers and directors concerning Company operations.
|
FSLR | Hot Stocks08:39 EDT First Solar commits to science-based emission targets, net zero emission by 2050 - First Solar announced a commitment to reduce its absolute Scope 1 and Scope 2 greenhouse gas emissions by 20% by 2028, relative to its emissions in 2020. It has also committed to achieving net zero emissions by 2050 at the latest. The science-based targets further the company's previous 2021 GHG intensity reduction target, which was achieved three years in advance of its commitment. Scope 1 accounts for direct GHG emissions from company-owned and controlled resources, while Scope 2 accounts for indirect GHG emissions from the generation of purchased electricity consumed by the company. "As this week's report from the Intergovernmental Panel on Climate Change showed, we need to treat the threat of climate change with a sense of urgency and do more than simply our part to accelerate the transition to a net-zero economy," said Mark Widmar, chief executive officer, First Solar. "The solar industry is on the forefront of the fight against climate change and has a responsibility to lead by example. While First Solar's technology addresses the need to decarbonize the global energy portfolio with ultra-low carbon solar, today, we're stepping up and pledging to reduce our already-low emissions to zero by 2050."
|
RVVTF | Hot Stocks08:39 EDT Revive says management not aware of any undisclosed material information - Revive Therapeutic announces that its management is not aware of any undisclosed material information relating to the Company that may be contributing to the recent increase in its trading activity.
|
SLGG | Hot Stocks08:38 EDT Super League Gaming established Young Gamer Network, Core Gamer Network - Super League Gaming announced the formation of its Young Gamer Network and Core Gamer Network to continue "driving elevated levels of audience engagement and awareness for the company's roster of high-profile advertisers, sponsors, and partners," the company said. "The increased level of excitement about Super League from ongoing and new partners since closing the acquisition of Mobcrush has been remarkable," said Matt Edelman, Chief Commercial Officer of Super League Gaming. "After integrating Mobcrush into the company, we saw a natural opportunity to establish clear audience segments around distinct demographics of gamers we now reach across every critical touch point - in-game, in-stream, in-content, and through compelling digital, and hopefully soon again, in-person experiences." Super League's Young Gamers Network enables unique reach to gamers under 18 and includes: Minehut; Mineville; Pixel Paradise; Multiple original series on Snapchat; Partnerships with a growing number of Roblox game developers and media platforms; and an expanding presence on Tik Tok. The company's Core Gamers Network presents opportunities to engage gamers 18-34 and includes: Mobcrush's reach across digital live streaming platforms to a Nielsen-verified U.S. audience; access to more than 200,000 AI-generated gameplay; Super League's esports invitational tournament series; the Framerate social media network; and Bannerfy.
|
SLGG | Hot Stocks08:36 EDT Super League Gaming announces acquisition of Bannerfy - The company announced the acquisition of Bannerfy, an intelligent technology platform that enables digital video and live streaming creators to collaborate with tier one sponsors on their social media channels including YouTube through scalable and custom premium placements. "The acquisition of Bannerfy reinforces Super League's commitment to helping creators monetize their fan base as they seek to turn their passion into their livelihood. Brands now will be able to access additional premium inventory from creators through Super League to establish an organic connection with their fans and followers," the company said. Bannerfy's industry-leading solution reduces the friction between creators and sponsors by delivering a seamless way for sponsors to be present in the creator's native environment. "The Bannerfy technology platform will be a revenue accelerator for Super League. Mobcrush creators globally will be able to monetize an additional component of their channels, and brands targeting creators outside of the US now will have access to the video inventory available through Mobcrush's Sponsored Live Breaks product offering," said Mike Wann, Chief Strategy Officer of Super League. "Regardless of size, qualified creators can begin cherry-picking the brands they want to work with and have transparent visibility into their inventory value across social platforms."
|
LQDA UTHR | Hot Stocks08:33 EDT US PTAB decides to institute IPR review of United Therapeutics' Tyvaso patent - Liquidia (LQDA) announced that the U.S. Patent Trial and Appeal Board, or PTAB, has instituted inter partes review, or IPR, against U.S. Patent No. 10,716,793, owned by United Therapeutics Corporation (UTHR) and listed in the Orange Book for Tyvaso. In deciding to institute the IPR with respect to the '793 patent, the PTAB stated that Liquidia had demonstrated a reasonable likelihood of prevailing in its assertion that all of the claims of the '793 patent are unpatentable as obvious over the combination of certain prior art cited by Liquidia in its petition to the PTAB. "The PTAB's decision to institute an IPR against the '793 patent is another important step forward for Liquidia's ongoing effort to bring LIQ861, a convenient and well tolerated inhaled dry powder formulation of treprostinil, to the PAH community. With a decision in the IPR for U.S. Patent No. 9,604,901 expected in October and our continued efforts in the ongoing litigation against United Therapeutics, we remain confident that the patents asserted against us will be found invalid and not infringed by Liquidia," stated Damian deGoa, Chief Executive Officer at Liquidia.
|
WKHS | Hot Stocks08:33 EDT Workhorse Group enters into pilot program with USDA's NRCS - Workhorse Group announced that it has entered into a pilot program with the U.S. Department of Agriculture's Natural Resources Conservation Service to demonstrate its ability to provide small Unmanned Aerial Systems as a service to support NRCS efforts in Mississippi. The NRCS is an agency of the USDA that provides technical assistance to farmers and other private landowners and managers by running voluntary programs and offering science-based solutions that benefit both the landowner and the environment. The NRCS conducts a daily wetland supervision process to audit the quality of drainage easements, dams, ponds, waterways, and various wetlands across thousands of areas of interest throughout the country. This process is currently conducted using satellite imagery as well as hundreds of employees to examine key checkpoints. The NRCS has entered into an agreement with Workhorse's Aerospace division to improve its supervisory efforts. As part of the pilot program, Workhorse will offer sUAS services, including monitoring via drone, data procurement and analytics. Automating the daily audits with the sUAS will allow the NRCS to expedite information delivery, increase safety for auditors on the ground, be more cost-effective, increase fidelity of the data gathered, and ultimately create a more efficient procedure. The first phase of the program involves the Company collaborating with NRCS agents to gain a field-level understanding of the program's deliverables before implementing its sUAS technology to gather actionable data and insights.
|
ALLO | Hot Stocks08:32 EDT Allogene Therapeutics receives Orphan Drug designation for ALLO-715 - Allogene Therapeutics announced that the U.S. Food and Drug Administration has granted orphan-drug designation to ALLO-715 for the treatment of multiple myeloma. Initial results from the Phase 1 UNIVERSAL study of ALLO-715 in relapsed/refractory multiple myeloma were presented at an oral session of the American Society of Hematology annual meeting in December 2020. In April 2021, ALLO-715 was granted Regenerative Medicine Advanced Therapy designation by the U.S. Food and Drug Administration. The UNIVERSAL trial continues to enroll patients to ALLO-715 including in combination with nirogacestat, a gamma secretase inhibitor from SpringWorks Therapeutics and in consolidation therapy.
|
AB | Hot Stocks08:32 EDT AllianceBernstein, LSV advisors announce strategic partnership - AllianceBernstein announced that the firm has established a strategic partnership with LSV Advisors, a special situations secondaries firm focused on liquidity solutions for hedge fund, private equity, and other alternative investment funds. The new partnership will enhance investment offerings for the firm's private wealth business, Bernstein Private Wealth Management. The goal of the partnership is to provide clients access to LSV's investment strategy to enhance their diversification in alternative investments. As a part of the broader strategic partnership, AB will become the exclusive private wealth partner for LSV. Founded in 2005, LSV is a pioneer in providing liquidity solutions for investors and managers of private funds, as well as direct private assets, and is currently investing its sixth round of investment funds.
|
MTCR | Hot Stocks08:31 EDT Metracrine expects cash, cash equivalents to fund operations through 2022 - Cash, cash equivalents and short-term investments were $74.8 million as of June 30, 2021. Metacrine believes it has sufficient capital to fund its current operating plan through 2022.
|
MTCR | Hot Stocks08:31 EDT Metracrine reports Q2 net loss $15.585M vs. $9.32M last year - "We are just a few months away from important clinical data readouts for both our MET409 and MET642 programs," said Preston Klassen, M.D., MHS, CEO, Metacrine. "We now expect to report data from an interim analysis of the MET642 trial in non-alcoholic steatohepatitis (NASH) patients early in the fourth quarter of 2021. We also affirmed that we are on track for our MET409 combination trial readout before the end of the year. Our team has done a fantastic job achieving enrollment targets for both studies, as we get ready to select the best candidate to move forward into late-stage development in both NASH and our planned expansion into inflammatory bowel disease in 2022. Our potentially best-in-class FXR agonist platform supports our vision of bringing new therapies to patients that have no treatment options today. The wider therapeutic index of our NASH program is achieved through balanced FXR activation in both the liver and intestine to deliver an optimal risk/benefit profile. With capital that takes us through our critical milestones in 2022, we remain focused on executing against our key objectives in the months ahead."
|
MTCR | Hot Stocks08:29 EDT Metracrine provides update on upcoming milestones - MET642 Phase 2a monotherapy trial interim analysis now expected early in the fourth quarter of 2021 - The company plans to report topline data of an interim analysis from its Phase 2a, 16-week, randomized, placebo-controlled, multi-center trial evaluating MET642 in patients with NASH early in the fourth quarter of 2021, previously fourth quarter of 2021, after 60 patients have completed 16 weeks of treatment. Topline trial results of up to 180 patients are still anticipated in the first half of 2022. MET409 Phase 2a combination trial results expected in the fourth quarter of 2021 - Metacrine expects to report topline data from Phase 2a trial evaluating MET409 in combination with empagliflozin, a sodium-glucose cotransport-2 inhibitor in patients with both type 2 diabetes and NASH, in the fourth quarter of 2021. The trial completed enrollment with over 120 patients in June 2021.
|
DZSI | Hot Stocks08:28 EDT DZS, Digicomm form strategic sourcing partnership - DZ announced a strategic sourcing partnership with Digicomm International. As a result of this strategic partnership, MSOs, incumbent telecommunications service providers, fiber overbuilders, municipalities, electric cooperatives and enterprise end-customers and resellers will receive timely and reliable sourcing of leading fiber-based broadband access, customer premises and 5G mobile transport solutions from DZS through Digicomm.
|
OPRT V | Hot Stocks08:27 EDT Oportun launches Oportun Visa Credit Card - Oportun (OPRT) announced the nationwide availability of the Oportun Visa (V) Credit Card. The Oportun credit card has been successfully piloted with more than 54,000 customers in the last 18 months. Unlike other card products that are available to financially responsible people with limited or no traditional credit history, the Oportun card is unsecured and offers starting credit lines of up to $1,000.
|
BDTX | Hot Stocks08:26 EDT Black Diamond Therapeutics provides update on upcoming milestones - BDTX-189: The company has selected the preliminary recommended Phase 2 dose for BDTX-189 and, pending dialogue with the U.S. Food and Drug Administration, is on track to initiate the Phase 2 portion of the study in the second half of 2021. BDTX-1535: Black Diamond continues to advance BDTX-1535 through IND-enabling studies and expects to file an IND application in the first half of 2022. Early-Stage Pipeline: Black Diamond continues to progress its early-stage pipeline programs designed to target cancers driven by mutations in BRAF and FGFR. The Company anticipates IND filings for the BRAF and FGFR programs in 2022.
|
APO | Hot Stocks08:25 EDT Apollo Global appoints Vikram Mahidhar as head of data, digital transformation - Apollo Global Management announced that Vikram Mahidhar has joined the Firm as an Operating Partner to lead Private Equity's Data & Digital Transformation efforts within Apollo's Portfolio Performance Solutions platform. In this role, Mr. Mahidhar joins an existing team of data and digital strategists to accelerate digital transformation across the firm's Private Equity portfolio companies using business intelligence, advanced analytics, digital marketing, artificial intelligence, and other proprietary capabilities. He will work closely with Andy Pickens, formerly of Palantir Technologies, who has led many of the APPS team's early successes since joining the Firm in 2018. The team has helped Apollo's companies across a diverse range of industries to create value through new data systems and enhanced technology, including Sun Country Airlines, McGraw Hill Education, Diamond Resorts, and Rackspace, among others. As part of Apollo's APPS platform, the Data & Digital Transformation team is designed to work alongside the Private Equity investment teams and its portfolio companies to transform their operational capabilities. The platform is comprised of experts and proprietary partnerships focused on key strategic priorities, including data, technology, talent, and innovation. Prior to joining Apollo, Mahidhar was a Senior Vice President at Genpact.
|
RCM | Hot Stocks08:23 EDT R1 RCM announces appointment of Agnes Scanlan to board of directors - R1 RCM announced the appointment of Agnes Scanlan, president of The Cambridge Group, to the company's board of directors, effective August 11, 2021. Bundy Scanlan has more than 30 years of experience across regulatory risk management, compliance, and consumer financial protection. She has served as president of The Cambridge Group, a regulatory risk management advisory firm, since May 2020.
|
CHRS | Hot Stocks08:22 EDT Coherus, Junshi announce Breakthrough Therapy designation for toripalimab - Shanghai Junshi Biosciences and Coherus BioSciences announced that the United States Food and Drug Administration has recently granted Breakthrough Therapy Designation for toripalimab in combination with chemotherapy for the 1st line treatment of recurrent or metastatic nasopharyngeal carcinoma. The FDA had earlier granted BTD for toripalimab monotherapy for patients with recurrent or metastatic NPC with disease progression on or after platinum-containing chemotherapy. Junshi Biosciences expects to complete the biologics license application ("BLA") submission for toripalimab plus chemotherapy for 1st line NPC and for toripalimab monotherapy for 2nd or 3rd line NPC later this quarter.
|
PRTG | Hot Stocks08:22 EDT Portage Biotech issues letter to shareholders - Portage Biotech issued the following letter to shareholders: "On behalf of the team at Portage Biotech, Inc., I am pleased to provide you with a corporate update, reflecting on the progress that we have made throughout the first half of 2021 and the foundation these accomplishments have built - both for the remainder of the year and for the future... Our lead asset and immediate value driver, the invariant natural killer T cell platform, bridges the innate and adaptive immune system, providing broad potential to reprogram the immune response and re-sensitize PD-1 resistant tumors... We are proud to say that we have entered the clinic, achieving the following milestones: Dosing the first patient in a Phase 1 study of PORT-3... and Dosing of the first patient in a Phase 1/2 study of PORT-2... In addition to our iNKT platform, we have also advanced development of PORT-1... The IT-01 study is ongoing with additional clinical data reads expected over the next 12-18 months, conducted in collaboration with and oversight by joint development teams with Bristol Myers Squibb and Merck. The team has expanded its collaboration efforts with the INVINCIBLE study, conducted by the Ottawa Hospital and the Ontario Institute for Cancer Research. The company plans on presenting updates from the INVINCIBLE and IT-01 studies at upcoming industry meetings... In the coming year we plan to progress our preclinical and clinical pipeline significantly. We are looking to accelerate preclinical development of our PORT-4 platform, which may potentially increase the potency and improve the safety of numerous anti-cancer drugs through co-delivery of combination treatments to the tumor, and our PORT-5 STING platform, which provides distinct advantages over chemical intratumoral approaches by offering a potent immune priming and boosting pathway within a virus-like particle to enable convenient systemic administration and traffic to the correct targets."
|
FB | Hot Stocks08:21 EDT Facebook, EDP Renewables, Salt River Project bring solar park to Arizona - EDP Renewables SA, through its fully owned subsidiary EDP Renewables North America, and Salt River Project have executed a 25-year power purchase agreement for 200 megawatts at the Randolph Solar Park in Pinal County, located in south-central Arizona. This announcement expands on the communication issued on July 27, 2021. The 200-MW Randolph Solar Park is expected to be operational in 2023 and will provide economic benefits to the local project communities and state of Arizona by way of payments to local landowners and governments, job opportunities during construction and operations, and an increase in money spent at local businesses in the vicinity of the solar park. Randolph will also generate enough electricity to annually power more than 49,000 average Arizona homes and will save approximately 355 million gallons of water a year. SRP's investment in the Randolph Solar Park is part of the utility's expanded commitment to add 2,025 MW of utility-scale solar resources to its power system by 2025 and serve customer energy needs with renewable energy. The entire capacity of the Randolph Solar Park will be dedicated to supporting Facebook's newly announced data center in Mesa, Arizona, and to help meet the company's renewable energy commitments.
|
GBT | Hot Stocks08:19 EDT Global Blood Therapeutics announces employment inducement grants - Global Blood Therapeutics announced that onAugust 1, 2021, the compensation committee of GBT's board of directors granted 12 new employees restricted stock units for an aggregate of 33,050 shares of the company's common stock. These awards were made under GBT's Amended and Restated 2017 Inducement Equity Plan. The above-described awards were each granted as an inducement material to the employees entering into employment with the company in accordance with NASDAQ Listing Rule 5635(c)(4), and were granted pursuant to the terms of the Plan. The Plan was adopted by GBT's board of directors in January 2017 and has been amended and restated from time to time.
|
CRBP | Hot Stocks08:18 EDT Corbus Pharmaceuticals provides updates on upcoming milestones - Lenabasum: The company expects topline data from the National Institutes of Health-sponsored Phase 2 study of lenabasum in systemic lupus erythematosus in Q4 2021. Cannabinoid receptor type 1 program: Program is on track for IND in 2022. Cannabinoid receptor type 2 program: Key preclinical data are expected in Q3 2021 that will guide the path to an IND. Anti-TGFbeta integrin monoclonal antibody (mAb) program: Pre-IND work has commenced, and the program is on schedule for anticipated IND in late 2022. CRB-602 for fibrotic diseases and cancer: Program is on schedule for an anticipated IND in early 2023.
|
MNPR | Hot Stocks08:16 EDT Monopar Therapeutics expects cash to fund operations through September 2022 - Cash and cash equivalents as of June 30, 2021, were $24.3 million. Monopar anticipates that its current cash and cash equivalents will fund the Company's major programs at least through September 2022, including: completing the Phase 2b portion of the VOICE clinical trial and commencing of the Phase 3 portion; funding the camsirubicin Phase 1b clinical trial; continuing advancement of the MNPR-101 RIT program including related compounds; continuing the development of MNPR-101 and related technologies in cancer; and developing MNPR-202 and related analogs in various cancers. The Company plans to raise additional funds and/or engage a partner within the next 12 months to complete the VOICE clinical program and continue the camsirubicin clinical development beyond the Phase 1b clinical trial.
|
FSTX | Hot Stocks08:14 EDT F-star Therapeutics announces expanded development strategy for FS118 - The Company announces an expanded clinical development strategy for FS118, F-star's first-in-class bispecific antibody targeting LAG-3 and PD-L1, into checkpoint inhibitor naive patients. This new study with FS118 is in biomarker enriched subsets of patients with non-small cell lung cancer and diffuse large B-cell lymphoma. By moving into earlier lines of therapy, FS118 has the potential not only to delay, but also to prevent checkpoint resistance, which could provide an alternative treatment for patients who do not see a durable benefit from currently approved immunotherapies In addition to the expanded FS118 clinical strategy, F-star has three other ongoing clinical stage programs. These programs are combined with a strong balance sheet, having closed an underwritten public offering of stock and its "at the market" facility during Q2, which will enable the company to deliver multiple clinical data milestones. At the end of the second quarter the company had over $80 million in cash and cash equivalents. In the past quarter, F-star has also delivered on clinical and business development objectives, specifically the recent interim Phase 1 update on SB 11285 and the announcement of two major collaborations, a licensing agreement with AstraZeneca Plc for STING inhibitors and a supply agreement with MSD to evaluate the combination of FS120, F-star's first-in-class dual-agonist, tetravalent, bispecific antibody targeting CD137 and OX40, with KEYTRUDA, MSD's anti-PD-1 therapy.
|
BCDA | Hot Stocks08:13 EDT BioCardia expects cash, cash equivalents to fund operations into Q4 of 2022 - The Company ended the quarter with cash and cash equivalents totaling $18.5M, providing anticipated operating runway into the fourth quarter 2022.
|
AESE | Hot Stocks08:13 EDT Allied Esports Entertainment says its schedule on Twitch boosts live views - Allied Esports announced that its 24-hour programming schedule on Twitch, featuring Allied Esports-produced tournaments and exclusive original content, has generated 13.4 million live views and 7.6 million unique views since its debut in November 2020. Allied Esports also added 46,752 Twitch followers during that time. In addition, Allied Esports has added four over-the-top streaming services for distribution of its tournament content through its previously announced agreement with streaming workflow platform MuxIP. "The market for esports content is growing rapidly, and we are all-in on delivering our popular tournament broadcasts to fans across a diverse set of digital platforms," said Jud Hannigan, CEO of Allied Esports. "As the past several months have proven, gaming fans want to watch competitive, high-quality content and with weekly productions across multiple continents, we have the ability to grow our distribution library and reach new audiences quickly and broadly." Allied Esports' around-the-clock Twitch programming includes a wide selection of recent and classic Allied Esports event broadcasts from North America and Europe. Highlights include online and LAN community competitions such as Knockdown! featuring Super Smash Brothers Ultimate, Frags featuring Fortnite and the Strafe Series featuring VALORANT; top-tier competition from the Legend Series and other professional tournaments; and original high-profile event productions, including Ninja Vegas '18 and PlayTime with KittyPlays.
|
IEC | Hot Stocks08:13 EDT Creation Technologies to acquire IEC Electronics for $15.35 per share in cash - IEC Electronics and Creation Technologies jointly announced the signing of a definitive merger agreement under which Creation will acquire all outstanding shares of IEC for $15.35 per share in cash, representing a fully diluted equity value of approximately $173.8 million and an aggregate enterprise value of $242.3 million, based upon net debt of $68.6 million. The transaction has been unanimously approved by the Boards of Directors of both companies. IEC is a leading provider of high-complexity, low-to-medium volume electronic manufacturing services focused on high-reliability applications within the aerospace and defense, medical and industrial end markets. With its marquee, blue-chip customer base, the company has proven its ability to service the industry's highest levels of quality and reliability. The merger will augment IEC's existing production capabilities with access to Creation's existing low-cost manufacturing facilities in Mexico. Creation Technologies is a global EMS supplier with a focus on medium volume, high-reliability customers in aerospace and defense, medical and tech industrial markets. Creation and IEC combined will have more than 4,000 employees in facilities located in the USA, Canada, Mexico and China. Under the terms of the merger agreement, Creation will commence a tender offer to acquire all of the outstanding common stock of IEC for $15.35 per share in cash. The purchase price represents a premium of approximately 47% to IEC's closing share price on August 11, 2021, the last full trading day before today's announcement. The tender offer is subject to customary closing conditions, including the tender of at least two-thirds of the total number of IEC's outstanding shares and the expiration of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Following the closing of the tender offer, a wholly-owned subsidiary of Creation will merge with and into IEC, with each share of IEC common stock that has not been tendered being converted into the right to receive the same $15.35 per share in cash offered in the tender offer. The transaction will be financed through a committed debt financing package provided by JPMorgan Chase Bank and Citizens Bank. The transaction is expected to close by early October 2021. The merger agreement provides for a "go-shop" period, during which IEC will actively initiate, solicit, facilitate, encourage and evaluate alternative acquisition proposals, and potentially enter into negotiations with any parties that offer alternative acquisition proposals. The "go-shop" period is 35 days subsequent to signing of the Merger Agreement, ending September 16, 2021. There can be no assurance that this "go-shop" process will result in a superior proposal. IEC does not intend to disclose developments with respect to the solicitation process unless and until its Board of Directors has made a decision with respect to any potential superior proposal. Upon completion of the transaction, IEC will become a privately-held company and shares of IEC's common stock will no longer be listed on any public market.
|
BCDA | Hot Stocks08:12 EDT BioCardia provides update on anticipated 2021 milestones - CardiAMP Chronic Myocardial Ischemia Phase III pivotal trial - first patient enrolled and roll-in cohort safety data. Investigational New Drug acceptance of Phase I/II program of our allogeneic Neurokinin-1 receptor positive Mesenchymal Stem Cells for the treatment of ischemic heart failure, intended initially for those patients excluded from BCDA-01. IND acceptance of Phase I/II program for BCDA-04, our allogeneic NK1R+ MSC Phase I/II program for the treatment of acute respiratory distress resulting from COVID-19.
|
TRP | Hot Stocks08:10 EDT TC Energy and Irving Oil partner in emission reduction projects in Canada - TC Energy and privately held Irving Oil have signed a memorandum of understanding to explore the joint development of a series of proposed energy projects focused on reducing greenhouse gas emissions and creating new economic opportunities in New Brunswick and Atlantic Canada. The two energy companies have identified a series of potential projects for exploration focused on decarbonizing current assets and deploying emerging technologies to reduce overall emissions. The partnership's initial focus will consider a suite of upgrade projects at Irving Oil's refinery in Saint John, New Brunswick, with the goal of significantly reducing emissions through the production and use of low-carbon power generation. he partnership will also explore opportunities that will aid in decarbonizing local industry over the medium- and long-term time horizons.
|
SELB | Hot Stocks08:10 EDT Selecta Biosciences expects cash to fund operations to Q3 of 2023 - Selecta had $151.5 million in cash, cash equivalents, marketable securities, and restricted cash as of June 30, 2021, which compares to cash, cash equivalents, and restricted cash of $149.2M as of March 31, 2021. Selecta believes its available cash, cash equivalents, marketable securities, and restricted cash will be sufficient to meet its operating requirements into the third quarter of 2023.
|
VACC | Hot Stocks08:10 EDT Vaccitech expects cash to fund operations into 1H24 - As of June 30, 2021, cash and cash equivalents were $243.6 million, compared to $43.3 million as of December 31, 2021. The increase was primarily due to completion of the Series B financing in the first quarter of 2021, which raised a further $125.3 million, and to the initial public offering in the second quarter, which raised gross proceeds of $110.5 million. The Company believes its cash and cash equivalents are sufficient to fund operations into the first half of 2024.
|
VACC | Hot Stocks08:09 EDT Vaccitech announces upcoming milestones - In the fourth quarter of 2021, the Company expects to announce topline safety and immunogenicity data from the Phase 1 trial of VTP-300, HBV001, in healthy volunteers and patients with chronic HBV infection. In the same quarter, the Company expects to initiate dosing in the Phase 1/2a trial of VTP-600 in patients with non-small cell lung cancer in combination with a checkpoint inhibitor and chemotherapy. In the first quarter of 2022, the Company intends to conduct an interim efficacy review, of HBV002, the Phase 1/2a clinical trial of VTP-300 in patients with chronic HBV infection. In the second quarter of 2022, the Company intends to conduct an interim efficacy review of HPV001, the Phase 1/2a clinical trial of VTP-200 in patients with high-risk and persistent HPV infection.
|
LGL | Hot Stocks08:08 EDT LGL Group to explore potential spin-off of MTronPTI business - LGL Group announced that its board of directors has authorized the company's management team to explore a potential spin-off of its MTronPTI business into a newly created and separately traded public company. The company said, "The LGL Group continues to strive for profitable growth internally and by acquisition. LGL believes that, if completed, the potential spin-off would enable shareholders to more clearly evaluate the performance and future potential of each entity on a standalone basis, while allowing each to pursue its own distinct business strategy and capital allocation policy. Separating MTronPTI as an independent, publicly owned company positions the business to increase value to both MTronPTI and LGL Group. The spin-off permits each company to tailor its strategic plans and growth opportunities, more efficiently raise and allocate resources, including capital raised through debt or equity offerings, flexibly use its own stock as currency for teammate incentive compensation and potential acquisitions and provide investors a more targeted investment opportunity. The LGL Group has successfully spun off several businesses over its history, including Lynch Interactive, The Morgan Group, Tremont Advisors and others. MTronPTI itself sought to become an independently listed company via an IPO, filing a form S-1 registration statement with Needham & Company as the underwriter in 2000. This IPO was pulled as a result of market conditions. MTron has an established and formidable presence in its key markets today and if the spinoff is completed, the standalone MTronPTI would continue providing market-leading engineered solutions to its defense and aerospace customers. The potential Spin-off is thus a continuation of the company's strategy of developing businesses and positioning them as independent entities to enhance shareholder value and alignment. If LGL proceeds with the spin-off, it would be structured as a tax-free, pro-rata distribution to all LGL shareholders as of a record date to be determined by the board of directors of LGL. If completed, upon effectiveness of the transaction, LGL shareholders would own shares of both companies."
|
TRHC | Hot Stocks08:08 EDT Tabula Rasa HealthCare expands partnership with eHealth for Medicare Plan review - Tabula Rasa HealthCare expanded its partnership with eHealth, a licensed online health insurance marketplace with more than 200 carrier relationships, to offer a complementary Medicare Plan Review module to all PrescribeWellness client pharmacies throughout the country. This partnership aims to enable pharmacists to engage and collaborate with patients on Medicare plan comparisons. The eHealth solution aims to help patients find the best available plan for their prescription drug needs while keeping them with their pharmacy.
|
CLSN | Hot Stocks08:07 EDT Celsion expects cash to fund operations through 2024 - The Company ended the second quarter of 2021 with $64.5 million in cash, investment securities, restricted cash and accrued interest receivable. Coupled with future sales of unused New Jersey NOL's, the Company believes it has sufficient capital resources to fund its operations through 2024.
|
OTRK | Hot Stocks08:07 EDT Ontrak appoints Arik Hill first Chief Information Officer - Ontrak announced the appointment of Arik Hill as Ontrak's first Chief Information Officer, effective August 30. Mr. Hill will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS Health earlier this year. "As Chief Information Officer at The New York Foundling, a fast growing organization that collaborates with over 250,000 behavioral healthcare partners across the country, Arik led the development of digital platforms and applications that leveraged AI and cutting edge technologies for value-based care, population health and the exchange of actionable insights with critical stakeholders," said Jonathan Mayhew, Ontrak CEO. "I'm very pleased that Arik will be joining the Ontrak leadership team at a time when we are making significant investments in the technology infrastructure required to support our enhanced care pathways, new product roadmap, market-leading engagement capabilities, and integration of interventions with key partners. In his new role, Arik will be responsible for technology architecture, engineering, data management, data science and analytics."
|
SELB | Hot Stocks08:06 EDT Selecta Biosciences reports Q2 EPS 0c, consensus (12c) - Reports Q2 revenue $19.66M, consensus $6.24M. "We are very pleased about our continued progress across all aspects of the company," said Carsten Brunn, Ph.D., president, and chief executive officer of Selecta. "Building on our ongoing empty AAV8 capsid study, we are rapidly advancing our two proprietary gene therapy programs into the clinic and as we enter a critical inflection point in development, we are honored to have gene therapy pioneer, Jude Samulski, Ph.D., join as a special advisor. The recently published preclinical data is encouraging and further supports the advancement of our lead candidate in methylmalonic acidemia (MMA), SEL-302. We will build on this momentum and expect to file an IND in MMA during the third quarter of 2021, bringing us one step closer to addressing immunogenicity constraints in AAV-driven gene therapy and ultimately, providing patients with potentially transformative treatment options. Additionally, we are steadily executing across our enzyme and autoimmune development program. We have a well-defined work plan ahead of us and the financial resources to maximize the value of our innovative ImmTOR platform."
|
EBAY | Hot Stocks08:06 EDT eBay to place luxury handbag machines in certain neighborhoods - With the luxury resale market seeing exponential growth in recent months and showing no signs of slowing down, eBay is bringing a lust-worthy selection of designer handbags from the marketplace directly into the hands of shoppers, with first-of-its-kind luxury handbag machines popping up in Dumbo, Brooklyn and Silver Lake, Los Angeles. For two days only, from August 12th through August 13th, shoppers visiting eBay's luxury handbag machines will have a chance to score a coveted bag from luxury's foremost brands, like the Hermes Birkin, Chanel Classic, Prada Diagramme and Louis Vuitton Nano Speedy Monogram. Style enthusiasts beyond the borders of Los Angeles and New York aren't out of luck, however: by heading to eBay's Instagram or Twitter, shoppers everywhere can play for a chance to grab a designer bag, all marked with eBay's Authenticity Guarantee.
|
DIN | Hot Stocks08:06 EDT IHOP soft launches libations menu in San Diego, New Mexico - IHOP unveiled its new libations menu of "Bubbles, Wine & Brews," available at select locations. The exclusive menu features domestically and locally sourced beers, as well as wine options. The new menu is available at three select IHOP restaurants in San Diego and New Mexico and will continue expansion to New York, Rhode Island, Maryland, Ohio and more in the coming months.
|
TENX | Hot Stocks08:05 EDT Tenax announces Phase 2 HELP study results including improved exercise tolerance - Tenax Therapeutics announced a new publication that identifies a novel mechanism of action behind the improved cardiovascular hemodynamics and exercise tolerance that was reported in the recent Phase 2 HELP Study.The HELP Study evaluated levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction . The new publication, "Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action" appears in the Journal of Cardiac Failure. The article is available online as an "Article In Press". The authors conducted an in-depth analysis of data from the HELP Study to elucidate the underlying mechanism behind the improved hemodynamic and exercise capacity effects seen in levosimendan-treated patients. Their analysis found that the reductions in pulmonary wedge pressure and central venous pressure were independent of any inotropic effect of the drug. Instead, the authors conclude that the reduction in PCWP and CVP shown in the HELP Study was attributable to levosimendan's ability to lower stressed blood volume through its effect on K+ATP channel activation. The splanchnic circulation is composed of the blood that supplies all of the abdominal viscera, and serves as a reservoir to increase or decrease venous return to the heart as dictated by physiologic conditions. It has been validated that dilating the splanchnic circulation will lower SBV and hence CVP and PCWP in PH-HFpEF As a result, patients have less shortness of breath and improved exercise tolerance.
|
FTFT | Hot Stocks08:05 EDT Future FinTech establishes UK subsidiary - Future FinTech has incorporated a new subsidiary, FTFT UK, as an operating base from which to develop fintech business in Europe. FTFT UK plans to provide high-quality digital inclusive financial services to individual customers and businesses through financial technology by building a new digital banking ecosystem based on blockchain technology to create a highly competitive financial services platform relative to traditional banks. The first phase will be to focus on the development of a 'super app' that will include a range of personal digital financial products and services. FTFT. FTFT UK has established a core team in the UK which is composed of a group of professionals in the field of consumer banking, payment systems and FinTech.
|
LXXGF | Hot Stocks08:05 EDT Lexagene Holdings reports on new study on MiQLab System - LexaGene announces that its MiQLab System is the first point-of-need system that can be configured to perform PCR using either probe-based chemistry or SYBR Green chemistry coupled with melt curve analysis. In a small study, LexaGene demonstrated the MiQLab successfully detected both Escherichia coli and an internal amplification control using SYBR Green chemistry. These two targets were distinguished by melt curve analysis of their respective PCR products Dr. Jack Regan, LexaGene's Founder and CEO stated, "To our knowledge, all other automated point-of-need instruments are only configured to perform with one type of chemistry, but the MiQLab System can effectively handle both. For some applications, we can use inexpensive SYBR Green chemistry to get the same quality answer we would normally get using the more expensive probe-based chemistry. For these types of applications, we have every motivation to use the less expensive chemistry to reduce costs. At our current volume of manufacturing and the MiQLab's typical reagent usage, changing from probe-based to SYBR Green based chemistry would equate to an ~20% reduction in the cost to screen a sample for 27 different targets of interest."
|
NKLA | Hot Stocks08:04 EDT Nikola awarded $2M U.S. Department of Energy grant - Nikola announced that they have been awarded an approximate $2M grant from the U.S. Department of Energy to advance its research into autonomous refueling technologies for future hydrogen fueling stations. Autonomous fueling is part of the industry's effort to ensure fast, efficient, and safe fueling of a large onboard storage system to be less than 20 minutes for heavy-duty vehicles. This project is expected to address this goal by working to develop an autonomous fueling system that can rapidly refuel heavy-duty fuel-cell electric trucks, while minimizing labor and challenges relating to ergonomics and maintenance of equipment, as compared to an equivalent manual fueling process.
|
PHAS | Hot Stocks08:03 EDT PhaseBio completes enrollment in REVERSE-IT trial - PhaseBio announced that it has enrolled the first 143 patients in its pivotal Phase 3 REVERSE-IT trial for its lead product candidate bentracimab, 138 of whom required urgent surgery or an invasive procedure and five of whom experienced uncontrolled major or life-threatening bleeding. The company is commencing preparation of the BLA and targeting a BLA submission to the FDA in mid-2022.
|
ARVL MSI | Hot Stocks08:02 EDT Arrival announces John Wozniak as Chief Financial Officer - Arrival (ARVL) announced it has appointed John Wozniak, former CVP of Finance Operations for Motorola Solutions (MSI), as Chief Financial Officer, effective August 23, 2021. Wozniak will be based out of the US and brings to Arrival extensive experience in corporate financial accounting, capital markets, and leading strategies in complex, global and growing businesses. John will succeed Tim Holbrow, Arrival's interim CFO, who will be continuing in a senior leadership finance role as SVP Strategic Finance. John will be responsible for leading Arrival's finance organization and support Arrival's expansion globally.
|
PDD | Hot Stocks07:58 EDT China Agricultural University joins Pinduoduo for 2021 Agriculture Competition - China Agricultural University will join Pinduoduo as a co-organizer of the Smart Agriculture Competition, a unique contest that aims to foster interdisciplinary innovation by marrying algorithms and agronomy. The Smart Agriculture Competition, which is being held for a second year, aims to promote the development of cost-effective technology that can help farmers to increase their productivity and improve their livelihoods in an environmentally sustainable manner. This year, the contest will draw teams from around the world to cultivate tomatoes using a combination of agronomic knowledge, algorithmic modeling, and precision automation. "As China's largest agriculture platform, Pinduoduo spearheaded the creation of the Smart Agriculture Competition as a way to gather the top minds in agronomy and computer science to develop technology that can improve agriculture and build a more resilient food system. The competition is advised by the Food and Agriculture Organization of the United Nations and Wageningen University & Research. Leading institutes including the Yunnan Academy of Agricultural Sciences and the National Plateau Yunguo Industrial Park are also lending their support," the company said. In this year's competition, judges will be evaluating the teams not only on yield and cost-effectiveness but also on the nutritional profile of the tomatoes and the environmental sustainability of their approach. This is in recognition of the important role that agriculture plays in the health of the population and its impact on the environment.
|
BABYF WMT | Hot Stocks07:56 EDT Else Nutrition enters distribution agreement with Walmart - ELSE NUTRITION HOLDINGS (BABYF) announces that it has signed an online distribution agreement with Walmart.com and will be expanding into Walmart's E-commerce (WMT) marketplace by Q4, 2021 with its Plant-Based Complete Nutrition products for Toddlers.
|
ADAG | Hot Stocks07:56 EDT Adagene announces appointment of interim CMO and new members of the SAB - Adagene announced appointment of an interim Chief Medical Officer, or CMO, and new members of its Scientific and Strategic Advisory Board, or the SAB. The appointments include pioneers in the immuno-oncology field: Steven Fischkoff, M.D., Stanley Frankel, M.D., FACP and Robert Spiegel, M.D., FACP. The new appointments include: Steven Fischkoff, M.D. - Dr. Fischkoff serves as the interim Chief Medical Officer of Adagene and is a member of the company's SAB. He is a board-certified medical oncologist who has been active in the pharmaceutical industry for approximately 30 years. Stanley Frankel, M.D., FACP - Dr. Frankel joins the SAB as a hematologist-oncologist with over 20 years of industry experience, including the research, clinical development, and commercialization of immuno-oncology and cellular therapies. He is Chief Medical Officer at Cytovia Therapeutics and is a Non-Executive Director at Precision Biosciences. He serves on the Scientific Advisory Board at Sutro Biopharma, Immunai, and Minerva Biotechnologies. Robert Spiegel, M.D., FACP - Dr. Spiegel joins the SAB with over 30 years of extensive R&D and operational experience in biopharmaceuticals and as an advisor to venture capital and private equity firms. Dr. Spiegel has been a consultant to the biotech industry and has served on the scientific advisory board and board of directors of multiple biotech companies.
|
VYNE | Hot Stocks07:44 EDT VYNE Therapeutics to explore sale of topical minocycline franchise - VYNE conducted a review of its commercial and research and development portfolio of assets to determine how to optimally deploy capital and maximize shareholder value. Following this review, the Company has determined to initiate a process to explore a sale or license of its topical minocycline franchise, including AMZEEQ, ZILXI and FCD105, as well as the underlying Molecule Stabilizing Technology platform specific to this portfolio. As VYNE transitions its focus and spend toward developing its pipeline, the Company expects to immediately reduce certain of its operating expenses currently supporting its commercial operations, but intends to maintain its sales force into the fourth quarter of 2021 while it seeks a commercial partner.
|
BLDR | Hot Stocks07:43 EDT Builders FirstSource announces $1B stock repurchase plan - Builders FirstSource announced that the board has authorized the Company to buy back up to $1 billion of its common shares.
|
PRLD | Hot Stocks07:43 EDT Prelude Therapeutics expects cash to fund operations into mid-2023 - Cash and cash equivalents as of June 30, 2021 were $343.1M. The company believes that its current cash and cash equivalents will be sufficient to fund operating expenses and capital expenditure requirements into mid-2023.
|
HYW C | Hot Stocks07:42 EDT Hywin Holdings appoints Wai Lok as CFO - Hywin Holdings (HYW) announced its Board of Directors has approved the appointment of Mr. Wai Lok to the position of Chief Financial Officer, effective on August 12, 2021, as the Company further bolsters its commitment to international standards of corporate governance and shareholder value, following its successful Initial Public Offering and listing on NASDAQ in March. Meanwhile, Mr. Zhou Huichuan, the previous CFO, will assume the role of Vice President of Strategic Projects and spearhead impactful initiatives. Prior to joining Hywin, Mr. Lok was a senior investment banker at Citigroup (C).
|
PRLD | Hot Stocks07:42 EDT Prelude Therapeutics provides information on upcoming milestones - PRT543: Dose Expansion Portion of Phase 1 Trial Ongoing; Data from Dose Escalation Portion to be Presented at the AACR-NCI-EORTC Annual Meeting: The Company will present data from the dose escalation portion of the Phase 1 trial in unselected patient populations, including safety, PK and PD data and markers of target engagement, at the AACR-NCI-EORTC Annual Meeting in October. The company expects to present data from the expansion cohorts at medical meetings throughout 2022. PRT811: Dose Expansion Portion of Phase 1 Trial Expected to Commence in 3Q21; Data from Dose Escalation Portion to be Presented at the AACR-NCI-EORTC Annual Meeting: The Company will present data from the dose escalation portion of the Phase 1 trial in unselected patient populations, including safety, PK and PD data and markers of target engagement, at the AACR-NCI-EORTC Annual Meeting in October. The company expects to present data from the expansion cohorts at medical meetings throughout 2022. PRT1419: Oral Formulation: Dose Escalation Portion of Phase 1 Trial Ongoing. The company expects to add dose expansion and combination cohorts to the Phase 1 clinical trial in the second half of 2021. IV Formulation: Dose Escalation Portion of Phase 1 Trial is Now Underway. Discovery Programs: Earlier-Stage Candidates Expected to Advance in 2021. The company remains on track to submit an Investigational New Drug pplication in 2021 for PRT2527, which is designed to be a potent and selective CDK9 inhibitor. In addition, the Company continues to expect to initiate IND-enabling studies for PRT-SCA2, which is designed to be a SMARCA2
|
FUN | Hot Stocks07:42 EDT Cedar Fair to invest $175M-$200M For 2022 season - "Cedar Fair Entertainment announced exciting plans for the 2022 operating season across all of its properties in the U.S. and Canada. These include a new themed area at Kings Dominion in Virginia, the reopening of two newly refurbished resort properties at Cedar Point in Sandusky, Ohio, and the 50th anniversary celebration at Kings Island in Mason, Ohio. In addition, Cedar Fair plans to introduce several new and upgraded dining venues and to expand its popular festival and event calendars to include something for everyone in the family throughout the year. "We're in the business of making people happy, and we are actively investing in our parks to help us deliver the type of fun, immersive experiences that our guests crave and our associates love to provide," said Cedar Fair President and CEO Richard A. Zimmerman. "Based on positive recent trends and our renewed confidence in the recovery of the business, we now plan to invest between $175-$200 million for the 2022 season to improve the guest experience at our parks. These investments include ongoing renovations at the Castaway Bay and Sawmill Creek resort properties at Cedar Point, as well as the addition of new rides, attractions and guest amenities across our parks in the U.S. and Canada."
|
AZRX | Hot Stocks07:41 EDT AzurRx completes initial cohort enrollment in RESERVOIR Phase 2 trial - AzurRx BioPharma announced that it has completed enrollment of the initial cohort into Part 1 of its ongoing RESERVOIR Phase 2 clinical trial evaluating FW-1022 as a treatment for COVID-19-related gastrointestinal infections. FW-1022 is a proprietary oral tablet formulation of micronized niclosamide for the treatment of COVID-19-related GI infections. Once all patients in this cohort complete their full two weeks of treatment, the trial's Data Monitoring Committee will review the safety data. Successful DMC review will then trigger enrollment into Part 2 of the trial, focused on demonstrating efficacy and extending safety observations. The RESERVOIR clinical trial is designed as a two-part, two-arm, placebo-controlled Phase 2 study. The trial's primary objectives are to confirm the safety of FW-1022 in the treatment of patients with COVID-19-related GI infections and to evaluate its efficacy in clearing SARS-CoV-2, the virus that causes COVID-19, from the GI tract. The primary efficacy measure of the RESERVOIR trial is the rate of fecal SARS2 clearance assessed by PCR, comparing the niclosamide arm to the placebo arm for up to six weeks. These long-term observation data could indicate that niclosamide treatment has the potential to improve "long haul" COVID-19 symptoms.
|
MKTY | Hot Stocks07:39 EDT EcoChain to acquire Soluna Computing - Mechanical Technology announced that it and its wholly-owned subsidiary EcoChain have entered into agreements for EcoChain to acquire Soluna Computing. Upon closing of the transaction, SCI will become a wholly owned subsidiary of EcoChain The combination will allow SCI to more easily access the capital and resources necessary to scale its renewable energy-powered data center solution more quickly and efficiently. Upon closing of the transaction, MTI plans to change its name to "Soluna Holdings." The transaction will place the Combined Company into the cryptocurrency mining industry's large-cap peer group based on its development pipeline. Upon the closing of the transaction, MTI will gain access to all SCI assets, including its 300MW pipeline that is currently under letters of intent, bringing EcoChain's combined total to 350MW, with over 200MW more under active development. EcoChain will directly employ or retain Soluna's top-tier technical and management team, bringing expertise in project development, energy markets, project finance and computing technology. EcoChain expects to have 50MW operational by the end of 2021 and another 50MW by the end of the second quarter of 2022. By the end of 2022, EcoChain expects to have two-thirds of Soluna's current pipeline operational. During 2021 EcoChain has been aggressively ramping up its capacity to meet its 50MW goal by the end of 2021. Based on current plans, EcoChain expects in August to increase its hash rate over July by 269% and that by the end of September, its hash rate will have increased by 863% from July. Upon closing, MTI acquires 300MW of green powered computing projects under LOI with costs well under $0.03 per KWh; Active global pipeline of over 200MW of additional projects; Soluna team is joining EcoChain with John Belizaire as CEO of the combined business unit, which we plan to rename "Soluna Computing"; MTI CEO Michael Toporek will continue to serve as CEO of the newly renamed Soluna Holdings. MTI continues to develop its business in a capital-efficient fashion with the acquisition of SCI. MTI will issue consideration to SCI as value is received to prevent any earnings dilution. Certain terms of the transaction are summarized below: 92% of total consideration is contingent upon projects coming online; $725,000 cash at closing; $75,000 for transaction fees and expenses at closing; 150,000 shares of MTI common stock issued at closing; Up to 2,970,000 shares of MTI common stock may be issued based on building out an additional 150MW: Contingent shares are not issued, escrowed or outstanding at closing For earnings per share calculations, the number of shares outstanding only changes when revenues are about to increase from a project coming online
|
VYNE | Hot Stocks07:38 EDT VYNE Therapeutics expects cash, cash equivalents to fund operations into Q2 2022 - As of June 30, 2021, VYNE had cash, cash equivalents, restricted cash and investments of $104.0M. The Company currently believes it has sufficient cash and cash equivalents to fund its operations through the end of the second quarter of 2022.
|
VYNE | Hot Stocks07:37 EDT VYNE Therapeutics announces licensing of BET Inhibitor Platform - VYNE Therapeutics announced that it has entered into an exclusive license agreement with In4Derm Limited, a spin-out of the University of Dundee's School of Life Sciences focused on the discovery and development of proprietary Bromodomain and Extra-Terminal Domain inhibitors for the treatment of immunology and oncology conditions. The University of Dundee is one of the foremost integrated university hospital and biotechnology research institutes in Europe. Topical BETi program: VYN201 is a first-in-class topical pan-BD BET inhibitor that is designed to mitigate systemic drug exposure and will be developed for topical applications. VYNE intends to progress VYN201 in rare, neutrophilic, dermatological indications where there is significant unmet need due to a lack of indicated treatment options. This program is expected to enter the clinic in 2022. Oral BETi program: VYNE expects to exercise its exclusive option with In4Derm to develop oral BET inhibitors following the selection of a lead candidate for the program. VYN202 is an orally-delivered, first-in-class BET inhibitor that is highly selective for Bromodomain 2. By selectively inhibiting BD2, the Company believes VYN202 could have a more targeted anti-inflammatory effect with an improved benefit/risk profile and views VYN202 as having significant potential as a novel, oral treatment for major immuno-inflammatory indications. Upon final candidate selection and exercise of its option, the Company intends to commence an IND-enabling non-clinical safety program and enter the clinic next year. There is substantial interest in BET inhibitors as therapeutic targets for a wide range of diseases. To date, much of the clinical research has been focused on oncology. The Company believes there is also compelling science to show that BET inhibition may play an important role in effectively treating immuno-inflammatory diseases. The parties previously entered into an Evaluation and Option Agreement pursuant to which In4Derm granted the Company an exclusive option to obtain exclusive worldwide rights to research, develop and commercialize products containing In4Derm's BETi compounds, which are new chemical entities, in both topical and oral treatments in all fields for any disease, disorder or condition in humans. On August 6, 2021, the Company exercised the Topical BETi Option and the parties entered into a License Agreement granting the Company a worldwide, exclusive license that is sublicensable through multiple tiers to exploit certain of In4Derm's BETi compounds identified to be suitable for topical administration in all fields. The Company paid a $1.0 million cash payment to In4Derm upon the execution of the Option Agreement and $0.5 million in connection with the exercise of the Topical BETi Option. Pursuant to the License Agreement, the Company has agreed to make cash payments to In4Derm upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed topical product in the U.S. of up to $15.75 million. In addition, the Company expects to exercise the Oral BETi Option following the selection of a lead candidate for the program. Upon exercise of the exclusive Oral BETi Option, the parties will sign a license agreement and the Company will pay In4Derm a $4.0 million cash payment. The Oral License Agreement will include cash payments of up to $43.75 million payable to In4Derm upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed oral product in the U.S. The license agreements also provide for tiered royalty payments of up to 10% of net annual sales across licensed BETi products by the Company. In4Derm is entitled to additional milestone payments upon the achievement of regulatory approvals in certain jurisdictions outside the U.S.
|
DDS | Hot Stocks07:36 EDT Dillard's reports Q2 EPS $8.81, consensus 54c - Reports Q2 revenue $1.57B, consensus $1.31B. Comparable store retail sales for Q2 compared to the second quarter of 2019 increased 14%. Dillard's reported net income for the 13 weeks ended July 31 of $185.7M, or $8.81 per share, compared to a net loss of $8.6M, or 37c per share, for the prior year second quarter. Included in net loss for the prior year second quarter is a net tax benefit of $17.4M, or 75c per share related to the Coronavirus Aid, Relief and Economic Security Act. Dillard's CEO William Dillard, II stated, "The strong consumer demand we saw in the first quarter continued throughout the second quarter. This momentum, combined with our continuing focus on inventory and expense control, produced a sequential record performance. We ended the quarter with $670 million in cash even after repurchasing $112 million of stock."
|
TLLTF | Hot Stocks07:35 EDT Tilt Holdings enters multi-state licensing agreement with 1906 brand - TILT Holdings announced a multi-state licensing agreement with cannabis product innovator brand 1906/ Through its subsidiaries Standard Farms, LLC in Pennsylvania, Standard Farms Ohio, LLC and Commonwealth Alternative Care in Massachusetts, TILT will provide full-service wholesale manufacturing, packaging and distribution services to accelerate the availability of 1906's portable, non-smokable cannabis products to patients in the rapidly-growing adult-use and medical markets that TILT serves. Since coming to market in Colorado in 2016, 1906 has been one of the fastest growing brands in the U.S. Pending regulatory approval, later this year TILT expects to launch 1906's zero-calorie, allergen-free pills in Pennsylvania and Ohio, as well as 1906's line of premium chocolates in Massachusetts, where their Drops are currently available to both medical patients and adult-use consumers. 1906 products are designed to deliver six unique experiences including*: Go - A special blend of plant medicines, caffeine, and cannabis promoting alertness, energy, and focus. Each Go Drop contains 5mg THC and 5mg CBD. Genius - An optimal blend of five plant medicines, caffeine, and cannabis promoting cognitive performance. Each Genius Drop contains 2.5mg THC and 2.5mg CBD. Bliss - A stimulating blend of euphoria-inducing plant medicines and cannabis promoting a bubbly sense of well-being and extroverted happiness. Each Bliss Drop contains 5mg THC and 5mg CBD. Love - An aphrodisiac made from five exotic herbs renowned for their love-enhancing properties, plus cannabis to increase sensuality. Each Love Drop contains 2.5mg THC and 2.5mg CBD. Chill - A perfectly balanced blend of stress-reducing plant medicines and relaxing cannabis promoting a tranquil mind and a calm body. Each Chill Drop contains 5mg THC and 25mg CBD. Midnight - A highly targeted blend of sleep-inducing plant medicines and relaxing cannabis promoting deeper and more restful nights. Each Midnight Drop contains 5mg THC and 5mg CBD.
|
PFE | Hot Stocks07:33 EDT VTX-801 receives Fast Track designation for treatment of Wilson Disease - Vivet Therapeutics and Pfizer announced the U.S. Food and Drug Administration has granted Fast Track designation to VTX-801, Vivet's clinical-stage gene therapy for the treatment of Wilson Disease - a rare, genetic disorder that reduces the ability of the liver and other tissues to regulate copper levels, causing severe hepatic damage, neurological symptoms, and potentially death. VTX-801 is a novel investigational gene therapy to be evaluated in a Phase 1/2 clinical trial to determine the safety, tolerability, and pharmacological activity of a single intravenous infusion in adult patients with Wilson Disease. Pfizer is collaborating with Vivet on the clinical supply of VTX-801 for the Phase 1/2 clinical trial.
|
JBLU | Hot Stocks07:29 EDT JetBlue announces nonstop service between NYs JFK and London's LHR - JetBlu announced it has officially entered the transatlantic market with new, nonstop service between New York's John F. Kennedy International Airport and London Heathrow Airport . The first customer-carrying JetBlue flight between the U.S. and the U.K. touched down at Heathrow just before 10 o'clock this morning, local time. The highly anticipated milestone - aimed at shaking up the transatlantic market with the airline's award-winning service and attractive fares - marks the first time JetBlue has served a destination beyond the 100+ cities it flies to throughout the Americas. With new service in the United Kingdom, JetBlue now operates in 26 countries. JetBlue's inaugural flight from New York-JFK to London Heathrow Airport arrives in the U.K. on August 12, 2021, marking the first-ever transatlantic service by the U.S.-based travel company. "For the first time in JetBlue's 21-year history we are crossing the North Atlantic and competing in one of the busiest travel markets in the world, well-positioned to introduce our award-winning service and low fares to a new global audience that is ready for a fresh choice in transatlantic flying," said Robin Hayes, chief executive officer, JetBlue. "With JetBlue now connecting New York and London, travelers finally have the ability to enjoy low fares while also experiencing superior service. As the U.K. opens to travelers coming from America, our flights are well timed to meet the pent up demand for travel between our two countries. We look forward to welcoming U.K. travelers to the U.S. soon and launching service between Boston and London next year."
|
NOVN | Hot Stocks07:28 EDT Novan expects cash to fund operating needs into 1Q23 - The Company believes that its existing cash and cash equivalents balance as of June 30, 2021, plus expected contractual payments to be received in connection with existing licensing agreements, will provide it with adequate liquidity to fund its operating needs into the first quarter of 2023, based on management's projections and planned operating and development activities described in the Company's quarterly report on Form 10-Q for the six month period ended June 30, 2021.
|
OCUP | Hot Stocks07:26 EDT Ocuphire Pharma sees cash runway into late 2022 - As of June 30, 2021, the Company had cash and cash equivalents of approximately $24.2 million. Net cash used in operating activities for the three and six months ended June 30, 2021, was $4.3 million and $10.1 million, respectively.
|
JCI APO | Hot Stocks07:24 EDT Johnson Controls, Apollo Infrastructure announce partnership - Johnson Controls (JCI) and funds managed by affiliates of Apollo Global Management (APO), announced a strategic partnership providing sustainability and energy efficiency services to help customers address decarbonization and operating cost goals for their buildings. The new venture is intended to provide customers across the United States and Canada with performance-based energy efficiency and smart buildings services at no upfront costs and with predictable monthly fees. The sustainability services will leverage Johnson Controls' decades of experience in energy efficiency performance contracting, along with its OpenBlue smart buildings technology and services, including the recently launched OpenBlue Net Zero Buildings as a Service. Apollo brings its infrastructure expertise and fund capital to offer customers flexible solutions to meet their energy savings and decarbonization objectives.
|
OCUP | Hot Stocks07:24 EDT Ocuphire Pharma announces anticipated future milestones - Reversal of Mydriasis: Initiate second Phase 3 (MIRA-3) registration trial and a small pediatric trial in the second half of 2021 investigating Nyxol with results expected in early 2022; Planning to file NDA submission with FDA for Nyxol in RM indication in late 2022; Presbyopia: Initiate Phase 3 program in first half of 2022 investigating Nyxol and LDP; Night Vision Disturbances: Completion of enrollment expected by year-end 2021 and top-line data expected in early 2022 from Phase 3 registration trial investigating Nyxol; Diabetic Retinopathy and Diabetic Macular Edema: Completion of enrollment in Phase 2 trial investigating APX3330 and top-line data expected in 2022.
|
PANW | Hot Stocks07:23 EDT Palo Alto Networks' Prisma Access solution achieves FedRAMP Authorization - Palo Alto Networks' Prisma Access has achieved Federal Risk and Authorization Management Program - FedRAMP - Moderate Authorization. With this authorization, Prisma Access can help U.S. government agencies secure their distributed workforce. Prisma Access offers government organizations scalable, cloud-delivered networking and security to protect their workforces while maintaining Trusted Internet Connection 3.0 compliance. FedRAMP provides a standardized approach to security assessment, authorization and continuous monitoring for U.S. government agencies as they increasingly embrace the cloud and use cloud-based products and services.
|
TIL | Hot Stocks07:21 EDT Instil Bio expects cash to fund operating plan into 2023 - As of June 30, 2021, cash and cash equivalents totaled $566.7 million, compared to $241.7 million as of December 31, 2020. The Company expects that its cash and cash equivalents as of June 30, 2021 will enable it to fund its operating plan into 2023.
|
SSTK OTEX | Hot Stocks07:20 EDT Shutterstock announces integration with OpenText - Shutterstock (SSTK) announced an API integration with OpenText (OTEX). The integration will offer Shutterstock Enterprise and OpenText customers direct access to 380M+ high-quality Shutterstock images via OpenText Media Management. OpenText Media Management, an industry-leading Digital Asset Management solution for brands and publishers, was named a leader in The Forrester Wave: Digital Asset Management for Customer Experience, Q4 2019.
|
AKUS | Hot Stocks07:20 EDT Akouos expects cash to fund operations for at least next two years - Cash, cash equivalents, and marketable securities were $271.8 million as of June 30, 2021, as compared to $308.0 million as of December 31, 2020. Akouos expects its cash balance to fund operations for at least the next two years.
|
PCT | Hot Stocks07:19 EDT PureCycle Technologies announces location of Plant 2 in Augusta, Georgia - "We continue to execute against our strategic objectives since our Q1 update call. PureCycle has announced the site location for Plant 2, our first cluster facility, in Augusta, Georgia, a selection based on the culmination of a comprehensive process. We are also executing on our plan for Plant 1 in Ironton, Ohio as cost and schedules remain on track," said CEO Mike Otworth. "We also made considerable advancements in our feedstock procurement strategy. Commercially, we are seeing a robust pipeline of demand with additional offtake agreements expected to close during Q3 and are progressing strategic partnerships in response to Asia's strong demand for PureCycle's purification technology. PureCycle has secured the capacity required to scale, is actively negotiating 300 million pounds of feedstock, and has validated our Feedstock+ pricing model for our next plant in Augusta. The bottom line is, PureCycle is on track and well positioned for success. We look forward to providing updates on our progress in the second half of 2021." The Company's Plant 1 in Ironton, Ohio remains on cost and schedule, while equipment is currently arriving on site. Module construction is expected to begin in Q3. PureCycle continues to expect commissioning of Plant 1 in 4Q22 with total installed capacity of 107 million pounds. PureCycle has already started the site selection process for the second cluster facility in North America that is anticipated to provide up to 390 million pounds of annual capacity with long lead equipment purchases expected in the first half 2022.
|
BFLY | Hot Stocks07:18 EDT Butterfly Network enters partnership with Caption Health - Butterfly Network and Caption Health announced that they have entered into an exclusive strategic partnership. For a broad set of healthcare professionals, Butterfly and Caption's integrated solution should enhance cardiac assessment by improving the ease of image capture and image interpretation in a variety of care settings including the hospital, clinic, and home.
|
TAST | Hot Stocks07:18 EDT Carrols Restaurant board approves extension to 2019 stock repurchase program - During the second quarter of 2021, the Company did not repurchase any shares of its common stock due to a limited trading window as a result of the private debt offering. The Board of Directors has approved an extension of the Company's 2019 stock repurchase program, which was set to expire on August 2, 2021 and has approximately $11 million of its original $25 million in capacity remaining. The Company's stock repurchase program will expire August 2, 2023, unless terminated earlier by the Board of Directors.
|
TAST | Hot Stocks07:17 EDT Carrols Restaurant declares special cash dividend of 41c per share - The Board of Directors declared a $25 million special cash dividend amounting to $0.41 per share on all issued and outstanding shares of common stock, including common stock issuable on the conversion of our Series B Convertible Preferred Stock. The special cash dividend will be paid on October 5, 2021 to shareholders of record as of the close of business on August 25, 2021. The Company's preliminary assessment is that the special cash dividend will be treated as a tax-free return of capital causing a reduction in a holder's adjusted tax basis in Carrols Restaurant Group, Inc. common stock. If a holder's basis is reduced to zero, any remaining portion of the special cash dividend would be taxed as capital gains. Final determination of the tax treatment will be based on Form 1099s that will be sent to holders in 2022. Holders should consult with their tax advisors to determine tax treatment of the special cash dividend.
|
CTSO | Hot Stocks07:17 EDT CytoSorbents granted second Breakthrough Device designation for DrugSorb-ATR - CytoSorbents announced that the company has been granted a second Breakthrough Device designation for its DrugSorb-ATR Antithrombotic Removal System by the U.S. FDA. This Breakthrough Device designation covers the removal of the Direct Oral Anticoagulants apixaban and rivaroxaban in a cardiopulmonary bypass circuit to reduce the likelihood of serious perioperative bleeding in urgent cardiothoracic surgery. It follows the Breakthrough Designation received in April 2020 to remove ticagrelor for the same application.
|
SIOX | Hot Stocks07:16 EDT Sio Gene Therapies provides information on upcoming milestones - AXO-AAV-GM1 gene therapy for GM1 gangliosidosis upcoming milestones: 12-month topline safety, biomarker, and efficacy data from the low-dose cohort in late Q3 or early Q4 2021; and meeting with the U.S. Food and Drug Administration to discuss the registrational pathway for AXO-AAV-GM1 in the first half of 2022. AXO-AAV-GM2 gene therapy for Tay-Sachs and Sandhoff diseases upcoming milestones: Expect continued patient identification, screening, and enrollment in Stage 1 of the dose-ranging trial throughout 2021. AXO-Lenti-PD gene therapy for Parkinson's disease upcoming milestones: Two GMP batches have been manufactured using an updated suspension-based process and have now completed fill and finish. Sio is awaiting final testing of these batches to support certification of at least one batch for use as clinical trial material by a Qualified Person in Q4 2021. Pending review and approval of an IMPD amendment by the MHRA in the U.K., we expect to resume enrollment of patients in the AXO-Lenti-PD clinical program in 2022.
|
MKTY | Hot Stocks07:16 EDT Mechanical Technology to acquire Soluna Computing, terms not disclosed - Mechanical Technology and Soluna Computing announced that they have signed a definitive agreement whereby MTI will acquire SCI. Soluna will buy excess energy from wind and solar farms to power data centers specializing in performing batchable computing, such as cryptocurrency mining. The transaction will launch Soluna into the new and rapidly growing "green" sector within the power-hungry data center industry. Upon closing of the transaction, the combined company will be renamed Soluna Holdings. The combined company will have a development pipeline of 350MW, with 50MW expected to be operational by the end of 2021 and another 50MW by the end of the second quarter of 2022. By the end of 2022, Soluna expects to have two-thirds of its current pipeline energized and operational.
|
SIOX | Hot Stocks07:14 EDT Sio Gene Therapies expects cash to sustain operations into 4Q22 - As of June 30, 2021, we had $111.0M of cash and cash equivalents. We hold no short-term or long-term debt on the balance sheet. We estimate that our current cash and cash equivalents will sustain our operations into Q4 2022, beyond the expected dates of major upcoming milestones for our AXO-AAV-GM1 gene therapy program for the treatment of GM1 gangliosidosis.
|
SLN | Hot Stocks07:13 EDT Silence Therapeutics announces anticipated milestones - Silence will host an R&D day in New York City on the morning of Thursday, October 21, 2021. The event will be webcasted live for those unable to attend in-person. More information will be made available via press release closer to the date.Additional results from the GEMINI healthy volunteer study of SLN124 will be presented at an upcoming medical congress, pending abstract acceptance.Topline data from the APOLLO phase 1 single-ascending dose study of SLN360 in people with high Lp(a) is now anticipated in the first quarter of 2022 versus the second half of 2021. The Company remains on-track to start phase 2 development in the second half of 2022 pending regulatory discussions. Topline data from the GEMINI II phase 1 single-ascending dose studies of SLN124 in people with thalassemia and MDS is now anticipated in the third quarter of 2022 versus the second half of 2021 primarily due to COVID-19.
|
TALS | Hot Stocks07:10 EDT Talaris Therapeutics provides update on future milestones - FCR001 in delayed tolerance induction. The company remains on track to initiate a Phase 2 trial for FCR001 in delayed tolerance induction in the fourth quarter of 2021. FCR001 in scleroderma. The company remains on track to initiate its first clinical trial in autoimmune diseases with its FREEDOM-3 trial in the fourth quarter of 2021. FCR001 in non-malignant blood, immune and metabolic disorders. The company remains on track to announce an additional target indication for FCR001 relating to a severe non-malignant blood, immune or metabolic disorder before the end of 2021.
|
LRMR | Hot Stocks07:10 EDT Larimar Therapeutics announces anticipated milestones - Obtain FDA clearance to initiate future clinical trials; Initiate a non-interventional healthy volunteer study this year to generate data for comparison to FA patients; Initiate Jive open-label extension clinical trial in the first half of 2022; Initiate MAD trial in patients under 18 years of age in the first half of 2022
|
ITOS | Hot Stocks07:08 EDT iTeos Therapeutics expects cash to fund requirements into 2026 - The Company had cash and cash equivalents of $302.9 million as of June 30, 2021, compared to $136.9 million as of June 30, 2020. Following receipt of the upfront payment from GSK pursuant to the Company's Collaboration and License Agreement earlier in August 2021, the Company believes that its existing cash and cash equivalents would enable it to fund operating expenses and capital expenditure requirements into 2026.
|
ZNTL | Hot Stocks07:06 EDT Zentalis expects cash to fund requirements into 3Q23 - As of June 30, 2021, Zentalis had cash, cash equivalents and marketable securities of $250.9 million. We believe that our existing cash, cash equivalents and marketable securities as of June 30, 2021, together with the net proceeds from our July 2021 follow-on offering, will enable us to fund our operating expenses and capital expenditure requirements into the third quarter of 2023.
|
PLTR | Hot Stocks07:06 EDT Palantir sees FY21 adjusted free cash flow over $300M - Sees FY21 adjusted free cash flow to in excess of $300M, up from in excess of $150M. Sees annual revenue growth of 30% or greater for 2021 through 2025.
|
IKNA | Hot Stocks07:03 EDT iKena Oncology expects cash to fund operations through 2023 - As of June 30, 2021, the Company had cash and cash equivalents totaling $264.0 million, which will fund operations through 2023. Net cash used in operations was $15.7 million for the second quarter of 2021 as compared to $7.7 million for the second quarter of 2020.
|
HOOK | Hot Stocks07:03 EDT Hookipa Pharma provides update on upcoming milestones - Upcoming Milestones: Additional HB-201/HB-202 Phase 1/2 data in HPV16+ cancers and recommended Phase 2 dose for the HB-200 program in the fourth quarter of 2021; HB-101 CMV Phase 2 data in the second half of 2021; Advancing the HB-300 program to IND for the treatment of metastatic prostate cancer; and HBV and HIV collaboration with Gilead Sciences advancing towards clinical studies.
|
BR | Hot Stocks07:01 EDT Broadridge raises annual dividend 11% to $2.56 per share
|
OCFT | Hot Stocks06:49 EDT OneConnect management to purchase $10M in company shares - OneConnect's CEO and certain other members of its management team intend to use their personal funds to purchase up to an aggregate of $10M worth of the company's ADSs during a three-month period, pursuant and subject to applicable laws and the company's securities trading policy. The management team has agreed to be subject to lock-up restrictions for a period of at least six months with respect to the proposed purchased shares.
|
TT | Hot Stocks06:44 EDT Trane and Nexii partner for sustainable commercial buildings - Trane and Nexii Building Solutions have joined forces to create sustainable commercial buildings with significantly reduced carbon footprints. The collaboration combines Nexii's expertise in building construction with Trane's digitally enabled EcoWise climate comfort systems to reduce energy usage and carbon emissions. Trane will be the exclusive North America heating, ventilation and air conditioning supplier for new, sustainable buildings constructed by Nexii including retail stores and restaurants. Nexii's building designs use a building system and proprietary material, "Nexiite," that minimizes embodied carbon, construction waste, and energy use, while reducing build times and costs versus conventional building products. Nexii's material Nexiite has comparable properties to concrete, but contains no Portland cement or lime, significantly reducing end-to-end carbon emissions. Nexii creates near-zero construction waste onsite.
|
PSN | Hot Stocks06:20 EDT Parsons authorizes stock repurchase for up to $100M - In a press release yesterday, the company announced that its board has authorized the repurchase of up to $100M of the company's common stock.
|
SEAS | Hot Stocks06:15 EDT SeaWorld announces COO resigning - In a regulatory filing, SeaWorld disclosed that on August 11, 2021, Tom Iven advised the company that he was resigning as Chief Operating Officer for personal reasons effective immediately. Iven will continue to assist the company through August 20, 2021.
|
MAXR | Hot Stocks06:13 EDT Maxar Technologies adds two international customers to its Rapid Access Program - Maxar Technologies added two new customers who signed multi-million-dollar contracts to subscribe to its Rapid Access Program - RAP -, including the first customer for RAP in Latin America. RAP provides customers with a web interface to virtually task Maxar's high-resolution satellites through on-demand access windows. Maxar delivers high-resolution imagery within hours of collection. By using cloud-based ground stations, RAP decreases the cost of actionable intelligence for customers. National Institute of Aeronautics and Space of Indonesia is Maxar's second RAP customer in the Asia-Pacific region. The Colombian Air Force is the second new RAP customer and the first international defense organization in Latin America to partner with Maxar in the program.
|
RDWR | Hot Stocks06:10 EDT Radware's cloud application security selected by Fortune 100 manufacturer - Radware has been selected by one of America's Fortune 100 manufacturing companies to support its hybrid cloud security strategy. In a multimillion-dollar agreement, this world leading manufacturer chose Radware's cloud application security to protect thousands of web applications hosted on Amazon Web Services, Microsoft Azure and a private cloud.
|
FNMA | Hot Stocks06:09 EDT Fannie Mae introduces feature to help include rent history in credit evaluations - Fannie Mae announced the company will launch a new feature in its automated underwriting system to incorporate consumers' rent payments in the mortgage credit evaluation process. Beginning September 18, 2021, Fannie Mae's Desktop Underwriter, or DU, will enable single-family lenders - with permission from mortgage applicants - to automatically identify recurring rent payments in the applicant's bank statement data to deliver a more inclusive credit assessment. "For qualified renters who may have limited credit history but a strong rent payment history, Fannie Mae's DU enhancement creates new opportunities for homeownership while promoting safe and sound lending," the company said. Only consistent rent payments will be considered to improve eligibility with the new update. Any records of missed or inconsistent rent payments identified in the bank statement data will not negatively affect the applicant's ability to qualify for a loan sold to Fannie Mae. "Many renters believe they will never be able to buy their own home because of insufficient credit. We can responsibly expand mortgage eligibility by including positive rent payment history in underwriting risk assessments," said Hugh Frater, Chief Executive Officer, Fannie Mae. "We believe this will be the first time any large-scale automated mortgage underwriting system will leverage electronic bank statement data to consider positive rent payment history. It is but one important step in correcting the housing inequities of the past, creating a more inclusive mortgage credit evaluation process going forward, and encouraging the housing system to develop new ways of safely assessing and determining mortgage eligibility in order to fairly serve all potential homeowners. We look forward to working with our industry partners to do what we can together to address this and other barriers to homeownership."
|
WBA | Hot Stocks06:09 EDT Walgreens Boots Alliance, VillageMD expand to Florida - Walgreens Boots Alliance and VillageMD announced the opening of three new Village Medical at Walgreens locations in the Orlando area with plans to open seven additional locations by end of this year. Through the Walgreens and VillageMD integrated care model, patients are able to receive convenient and coordinated pharmacy services alongside cost-effective and comprehensive primary care. These Village Medical at Walgreens locations in Florida will create approximately 400 jobs within the community, including 200 STEM high-paying, professional positions.
|
APRE | Hot Stocks06:07 EDT Aprea Therapeutics' lymphoid malignancy program put on clinical hold by FDA - Aprea Therapeutics announced that the FDA has placed a clinical hold on its clinical trial evaluating eprenetapopt with acalabrutinib or with venetoclax and rituximab in lymphoid malignancies. No additional patients can be enrolled until the clinical hold is resolved, though patients on study deriving clinical benefit can continue to receive study treatment. Subsequent to receiving notification of a partial clinical hold on its myeloid malignancies program, Aprea was informed by FDA of a clinical hold on its lymphoid malignancy study. The FDA's concerns referred to the safety and efficacy data from the Phase 3 MDS clinical trial. One CLL patient is currently on study treatment receiving eprenetapopt in combination with venetoclax and rituximab and has achieved complete remission. Aprea intends to work with the FDA to address the specific questions raised, and seek to resolve the clinical hold as soon as possible.
|
PBTS... | Hot Stocks06:06 EDT Powerbridge to engage in cryptocurrency mining - Powerbridge (PBTS) announced that it plans to invest and engage in the cryptocurrency mining for Bitcoin ($BTC) and Ethereum ($ETH), with planned operations globally. The company has assembled a team of industry veterans in cryptocurrency and technology to support the development and growth of its digital asset business.
|
BIDU | Hot Stocks05:55 EDT Baidu appoints CFO Herman Yu as chief strategy officer - Baidu announced that Herman Yu has been appointed as chief strategy officer, or CSO, of the company, and will be responsible for corporate strategy and business development. Yu will report to Baidu's CEO Robin Li. Yu will continue to serve as CFO until the appointment of a new CFO.
|
RIDE | Hot Stocks05:44 EDT Lordstown Motors to begin 'limited' production of Endurance in 2021 - Lordstown Motors said in its earnings report on Wednesday that it plans to begin "limited" production of its Endurance electric truck in late September. Production in 2021 will be limited to coincide with the commercialization roadmap, the company said. "We are launching the Endurance with a prudent ramp of production given a challenging industry and supply chain landscape. We are on track to begin limited production at the end of September and through the fourth quarter and complete vehicle validation and regulatory approvals in December and January. This will be followed by deployments with selected early customers in Q1 in advance of commercial deliveries in early Q2, with the ramp steepening the second half of next year," it added.
|
AMZN WH | Hot Stocks05:32 EDT Wyndham Hotels & Resorts selects AWS as cloud provider - Amazon Web Services, or AWS, an Amazon.(AMZN) company, announced a collaboration with Wyndham Hotels & Resorts (WH) to upgrade its technology infrastructure and develop and deliver new guest services across its 21 hotel brands. The company said moving to AWS enables Wyndham to enhance business performance, reinvest approximately 45% of reduced data center operating costs, and shut down additional physical datacenters, putting it on track to achieve its goal of running 90% of its infrastructure in the cloud. The announcement is part of Wyndham's multiyear digital transformation and investment in technology that automates hotel reservations, supports its franchisees by helping simplify operations.
|
FREY | Hot Stocks05:28 EDT Freyr Battery enters two non-binding MoU for scaling of battery cell production - Freyr Battery has entered into two non-binding memoranda of understanding, or MoU, with Finnish Minerals Group and the City of Vaasa, respectively, for strategic collaborations on potential development of industrial scale battery cell technology and production in Finland. The company said the Nordic region offers competitive advantages for sustainable, low-carbon battery cell production at scale through low-cost renewable energy, local supply of battery raw materials and highly skilled employees. Freyr plans to develop up to 43 GWh of battery cell production capacity by 2025 with an ambition of up to 83 GWh in total capacity by 2028 to position the company as one of Europe's largest battery cell suppliers. Finnish Minerals Group acts as a holding company in Finnish mining and chemical industry providing low-carbon materials to the battery industry and is supportive of establishing local Nordic and European battery technology supply chains. The MoU with the City of Vaasa provides Freyr with the exclusive right to a 90-hectare site for a potential battery cell plant and states that the parties will explore opportunities for joint site-development to accelerate supply of low-carbon and low-cost batteries in Finland.
|
NOK | Hot Stocks05:23 EDT Nokia provides private 4.9G/LTE wireless network to Western Power Distribution - Nokia announced that it has provided a private 4.9G/LTE wireless network to Western Power Distribution in the UK. The private LTE network will be used for supervisory control and data acquisition testing, as well as other systems such as voice services. WPD's "LTE Connecting Futures" trial is testing a new LTE network to enable its smart grid. The 4.9G/LTE core, radio and user equipment were supplied by Nokia for WPD's research at its Test and Development Center in Taunton, UK.
|
AJG | Hot Stocks05:22 EDT Arthur J. Gallagher buys majority stake in Brokers' House, terms undisclosed - Arthur J. Gallagher announced that it has purchased a majority stake in Turkish specialty broker Brokers' House. Terms of the transaction were not disclosed. Based in Istanbul, Brokers' House is a commercial insurance and facultative reinsurance broker offering clients a range of commercial and specialty coverages, including property, financial lines, energy, engineering and marine cargo. Brokers' House has been a Gallagher global network partner since 2014. The current leadership team of Gunduz Tezel and Levent Ozbilen will remain with the business.
|
J | Hot Stocks05:15 EDT Jacobs selected to carry out engineering modifications at South Africa plant - Jacobs was selected to carry out essential engineering modifications as part of a $1.2B program to extend the operating life of the Koeberg Nuclear Power Plant near Cape Town, South Africa. Koeberg is South Africa's sole nuclear power plant and generates 5% of the country's electricity. The project is in preparation for the installation of six replacement steam generators, each weighing about 380 tons and about 20 meters long, at the two-reactor plant operated by Eskom. Jacobs will be responsible for construction management related to modifications to the secondary turbine system. The scope of work includes prefabrication of piping, pipe supports and modification, and piping replacement; installation of on-site scaffolding, rigging and lagging; vessel modifications and strengthening; and replacement of forced air cooler units. Work on replacing the steam generators for the first of Koeberg's two units is scheduled to start during a planned outage in January 2022, with the overall project taking two years to complete.
|
FRSG EOC | Hot Stocks05:13 EDT EO Charging to go public through First Reserve Sustainable Growth combination - Juuce Limited, which trades as EO Charging, a provider of technology-enabled turnkey solutions for electric vehicle, or EV, fleets, and First Reserve Sustainable Growth (FRSG), announced a definitive agreement for a business combination that would result in EO becoming a publicly listed company. Upon closing of the transaction, which is expected to occur in Q4, the combined company will be named EO Charging and will be listed on the Nasdaq under the symbol (EOC). EO was founded in 2014 and headquartered in the UK. EO has deployed approximately 50,000 chargers in more than 35 countries worldwide since inception. The transaction implies a pro-forma enterprise value of the combined company of $675M and is expected to provide $222M in gross proceeds assuming no redemptions by FRSG's public stockholders. Total proceeds include over $150M to fully-fund EO's growth plans, retire any outstanding indebtedness, and for transaction fees and expenses, with the remainder paid as cash consideration to existing shareholders, in addition to the equity in the combined company to be received by existing shareholders. Charlie Jardine, as CEO of the combined company, will drive EO's strategic growth initiatives and expansion working alongside EO's existing executive team. The transaction has been unanimously approved by the boards of EO and FRSG. Completion of the proposed transaction is subject to customary closing conditions, including the approval of FRSG's stockholders, and is expected to occur in Q4 of 2021.
|
FVRR | Hot Stocks05:05 EDT Fiverr announces launch of Seller Plus subscription - Fiverr announced the launch of Seller Plus, a subscription based loyalty program for freelancers. For $29 a month, freelancers who subscribe to the program can access a suite of benefits that include a dedicated success manager, faster payment clearance, growth program priority, priority support, advanced analytics and customer engagement tools, as well as exclusive events and educational content.
|